Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016701	p-glu/2h	mmol/l (mmol/l)	1306	1812	0.00%
3016701	p-glukr2h	mmol/l (mmol/l)	829	897	0.00%
3016701	p-gluk-2h	mmol/l (mmol/l)	650	883	0.00%
3016701	glukr2h	mmol/l (mmol/l)	506	780	0.00%
3016701	p-glukr2h	mmol/L (mmol/l)	451	704	0.00%
3016701	gluk120min	— (—)	334	349	100.00%	Distribution not available
3016701	p-gluk-2t	mmol/l (mmol/l)	316	460	0.00%
3016701	fp-glukoosi(gluk.ras2h)	mmol/l (mmol/l)	214	225	0.00%
3016701	gluk2h	mmol/l (mmol/l)	199	280	0.00%
3016701	p-gluk/2h	mmol/l (mmol/l)	186	204	0.00%
3016701	p-gluk-2h	— (—)	159	259	100.00%	Distribution not available
3016701	fp-gluk-2	mmol/l (mmol/l)	135	168	0.00%
3016701	glukras120	mmol/l (mmol/l)	119	153	0.00%
3016701	glukoosi120min	mmol/l (mmol/l)	113	119	0.00%
3016701	glukr-2h	MMOL/L (mmol/l)	113	144	0.00%
3016701	p-gluk2h	— (—)	110	129	100.00%	Distribution not available
3016701	fp-gluk-2h	mmol/l (mmol/l)	96	109	0.00%
3016701	p-gluk2h	MMOL/L (mmol/l)	61	69	0.00%
3016701	p-glukr2h	— (—)	59	61	100.00%	Distribution not available
3016701	glukoosikoe,2hnäyte	mmol/L (mmol/l)	59	62	0.00%
3016701	p-gluk-2t	— (—)	54	59	100.00%	Distribution not available
3016701	fp-glukr2h	mmol/l (mmol/l)	46	50	0.00%
3016701	p-glukoosi2h	mmol/l (mmol/l)	46	53	0.00%
3016701	p-gluk-2	mmol/l (mmol/l)	40	57	0.00%
3016701	p-glu/2h	— (—)	33	33	100.00%	Distribution not available
3016701	p-glukgr2	mmol/L (mmol/l)	31	33	0.00%
3016701	p-glukoosi,2h	mmol/l (mmol/l)	28	36	0.00%
3016701	p-gluk2h	mmol/l (mmol/l)	17	23	0.00%
3016701	p-gluk/2h	— (—)	14	17	100.00%	Distribution not available
3016701	p-gluk(2	mmol/l (mmol/l)	14	18	0.00%
3016701	p-gluk2t	mmol/l (mmol/l)	13	13	0.00%	Distribution not available
3016701	s-glukoosi,2hnäyte	mmol/l (mmol/l)	13	13	0.00%
3016701	s-glukr2h	mmol/l (mmol/l)	11	11	0.00%	Distribution not available
3016701	fp-gluk-2	— (—)	9	9	100.00%	Distribution not available
3016701	p-glukoosi,2hnäyte	mmol/l (mmol/l)	8	8	0.00%
3016701	p-gluk-2	— (—)	5	5	100.00%	Distribution not available
3016701	p-gluk(2)	mmol/l (mmol/l)	5	5	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Contact with and exposure to communicable diseases

811

2466

3.39

214.14

1.5

6.47

6.68

mmol/l

1.47

791

2224

Persons with potential health hazards related to communicable diseases

862

2901

3.03

189.50

1.5

1.4

6.58

6.78

mmol/l

1.27

841

2601

Postpartum care and examination

391

444

5.78

170.92

1.6

1.3

6.42

7.17

mmol/l

4.61

376

393

Diabetes mellitus in pregnancy

781

1714

2.98

148.43

1.8

1.3

6.98

6.43

mmol/l

7.36

710

1573

Other maternal disorders predominantly related to pregnancy

907

2543

2.27

101.27

1.6

1.3

6.93

6.75

mmol/l

1.22

834

2307

Type 2 diabetes, definitions combined, including avohilmo

1223

3711

1.92

88.03

1.4

1.3

9.11

6.34

mmol/l

115.10

1082

3293

Single delivery by caesarean section

310

455

3.99

87.86

1.6

1.2

6.59

7.58

mmol/l

6.38

282

419

Outcome of delivery

321

548

3.70

84.50

1.5

1.2

6.52

7.20

mmol/l

3.19

314

483

Single delivery by forceps and vacuum extractor

252

351

4.40

81.98

1.7

1.2

6.39

7.54

mmol/l

8.25

234

331

Maternal care for other known or suspected fetal problems

483

1130

2.75

79.82

1.8

1.4

6.43

6.70

mmol/l

1.68

443

1030

Gestational diabetes (for exclusion)

760

2436

2.19

79.65

1.8

1.4

7.01

6.44

mmol/l

8.45

700

2242

Non-invasive ventilation

402

1282

2.75

73.36

1.3

7.21

6.32

mmol/l

6.50

362

1134

Single spontaneous delivery

438

845

2.78

70.80

1.6

1.2

6.65

7.75

mmol/l

11.61

387

736

Delivery, wide proxy

368

649

3.05

70.01

1.6

1.2

6.59

7.74

mmol/l

10.32

330

557

Type 2 diabetes, strict (exclude DM1)

1153

3793

1.78

65.97

1.4

1.3

9.22

6.41

mmol/l

107.13

1021

3361

Delivery

428

846

2.70

65.90

1.5

1.2

6.60

7.74

mmol/l

12.80

382

737

Type 2 diabetes, definitions combined

1149

3782

1.78

65.61

1.4

1.3

9.21

6.41

mmol/l

106.71

1018

3350

Other nutritional deficiencies

930

4635

1.85

65.54

1.6

1.3

7.34

6.91

mmol/l

4.70

825

4149

Pregnancy, childbirth and the puerperium

306

520

3.11

59.93

1.5

1.2

6.78

7.70

mmol/l

5.26

272

444

Obesity due to excess calories

696

3596

1.96

59.22

1.6

1.4

7.41

6.86

mmol/l

5.32

614

3244

Prolonged pregnancy

319

1005

2.78

58.64

1.7

1.4

6.08

6.66

mmol/l

4.01

299

919

Abnormal findings on antenatal screening of mother

227

713

3.31

58.11

1.8

1.4

6.32

6.22

mmol/l

0.34

203

661

False labour

503

1383

2.30

58.01

1.6

1.3

6.42

6.80

mmol/l

2.96

465

1252

Obesity and other hyperalimentation

860

4579

1.78

53.96

1.6

1.3

7.40

6.91

mmol/l

5.74

764

4096

Obesity

856

4570

1.78

53.50

1.6

1.3

7.40

6.90

mmol/l

5.74

761

4087

Other symptoms and signs involving the urinary system

167

457

3.75

52.64

1.3

7.63

7.43

mmol/l

0.31

162

393

Sleep apnoea, including avohilmo

1076

3886

1.68

51.26

1.3

7.42

7.14

mmol/l

2.31

959

3425

Endocrine, nutritional and metabolic diseases

976

2865

1.73

49.24

1.4

1.3

7.57

6.23

mmol/l

33.80

886

2567

Continuous positive airway pressure

228

642

3.00

48.70

1.2

7.66

6.51

mmol/l

6.13

185

549

Sleep apnoea

979

3653

1.70

48.68

1.2

1.3

7.52

7.23

mmol/l

2.17

866

3209

Maternal care for known or suspected abnormality of pelvic organs

413

1276

2.22

45.25

1.7

1.3

6.70

6.85

mmol/l

0.65

381

1148

Maternal care related to the fetus and amniotic cavity and possible delivery problems

608

1868

1.93

44.72

1.6

1.3

6.69

6.98

mmol/l

1.83

556

1682

Type 2 diabetes

1120

4049

1.61

44.55

1.4

1.3

9.25

6.38

mmol/l

104.43

990

3605

Antenatal screening

322

741

2.47

42.61

1.6

1.2

6.42

7.23

mmol/l

5.50

295

656

Other (not insulin) diabetes medications

1082

3979

1.61

42.60

1.4

1.3

9.39

6.48

mmol/l

105.97

953

3523

Other obstetric conditions, not elsewhere classified

604

2075

1.87

40.53

1.7

1.5

6.32

6.55

mmol/l

1.98

568

1903

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

594

2039

1.86

39.74

1.7

1.5

6.33

6.54

mmol/l

1.66

559

1870

Supervision of high-risk pregnancy

284

703

2.47

38.33

1.6

1.2

6.67

7.22

mmol/l

2.84

266

622

Maternal care for other conditions predominantly related to pregnancy

346

1589

2.16

38.22

1.7

1.3

6.64

6.49

mmol/l

0.57

314

1454

Insulin, intermediate and long-acting

100

3176

0.30

35.00

1.5

1.3

10.94

7.30

mmol/l

5.18

2761

Diabetes, varying definitions

1124

4310

1.52

34.96

1.4

1.3

9.21

6.35

mmol/l

104.28

1000

3846

Diabetes mellitus

1129

4329

1.51

34.46

1.4

1.3

9.23

6.34

mmol/l

103.75

1005

3863

Maternal care for known or suspected malpresentation of fetus

309

1024

2.19

33.26

1.7

1.4

6.27

6.67

mmol/l

2.84

290

932

Episodal and paroxysmal disorders

1183

4045

1.49

32.69

1.3

1.4

7.14

6.98

mmol/l

1.12

1067

3589

Biguanides

982

3887

1.53

32.12

1.4

1.3

9.46

6.51

mmol/l

97.99

860

3439

Insulin, fast-acting or short human

2229

0.20

31.56

1.3

11.65

7.21

mmol/l

3.50

1950

Insulin, fast-acting

2224

0.20

31.47

1.3

11.65

7.15

mmol/l

3.57

1951

Long labour

377

1666

1.95

30.80

1.6

1.4

6.69

6.68

mmol/l

0.04

339

1508

Insulin, combination of fast acting with intermediate-acting or long-acting

151

3471

0.39

30.56

1.7

1.3

9.94

7.25

mmol/l

6.29

120

3027

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1160

4226

1.46

29.79

1.3

7.21

7.06

mmol/l

1.00

1058

3692

Acute upper respiratory infections of multiple and unspecified sites

874

4183

1.53

29.61

1.4

1.3

6.97

7.03

mmol/l

0.28

802

3704

Supervision of normal pregnancy

276

722

2.21

29.01

1.5

1.2

6.27

7.25

mmol/l

8.82

254

638

Hypertension, essential

765

2735

1.59

29.00

1.3

7.81

6.97

mmol/l

8.97

694

2405

Labour and delivery complicated by fetal stress [distress]

404

1414

1.89

28.52

1.7

1.5

6.40

6.53

mmol/l

0.61

376

1292

Polyhydramnios

105

322

3.38

28.20

1.8

1.4

6.57

6.94

mmol/l

1.06

289

Hypertension

778

2814

1.57

27.80

1.2

1.3

7.81

6.94

mmol/l

9.96

704

2479

Hypertensive diseases

778

2816

1.57

27.74

1.2

1.3

7.81

6.94

mmol/l

9.98

704

2481

Complications of labour and delivery

706

2468

1.60

27.39

1.5

1.4

6.95

6.90

mmol/l

0.17

645

2214

Diabetes medication

1093

4471

1.43

25.70

1.4

1.3

9.37

6.42

mmol/l

102.20

967

3984

Insulin medication

151

2893

0.43

24.37

1.7

1.3

9.94

6.54

mmol/l

9.20

120

2526

Persons encountering health services in other circumstances, wide

1155

4227

1.41

24.18

1.3

7.25

7.06

mmol/l

1.33

1057

3692

Other special examinations and investigations of persons without complaint or reported diagnosis

717

2356

1.55

23.94

1.3

7.13

6.94

mmol/l

0.94

636

2096

Premature rupture of membranes

305

1139

1.93

23.75

1.6

1.4

6.52

6.74

mmol/l

1.04

289

1027

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

595

3304

1.57

23.42

1.6

1.4

6.91

6.78

mmol/l

0.61

540

3012

Gestational [pregnancy-induced] hypertension

389

2249

1.75

23.36

1.6

1.5

6.93

6.68

mmol/l

1.14

349

2060

Obstructed labour due to malposition and malpresentation of fetus

330

1683

1.84

23.26

1.6

1.4

6.57

6.69

mmol/l

0.44

306

1522

Hypertensive diseases (excluding secondary)

568

2062

1.61

23.11

1.3

7.91

6.88

mmol/l

10.12

517

1817

Pregnancy examination and test

186

506

2.31

22.28

1.6

1.2

6.63

7.18

mmol/l

1.90

169

445

Disease of hard tissues of teeth, NOS

478

1519

1.66

21.21

1.3

1.2

7.43

7.28

mmol/l

0.44

429

1295

Persons encountering health services in circumstances related to reproduction

534

2282

1.58

20.50

1.3

1.2

6.85

7.37

mmol/l

3.99

491

2008

Additional codes for the location of defect, injury or illness

281

3.10

20.17

1.4

1.3

7.00

7.29

mmol/l

0.32

246

Diabetic retinopathy, excluding more controls

1196

0.34

19.92

1.2

1.3

9.55

9.15

mmol/l

0.44

1054

Other diseases of hard tissues of teeth

478

1528

1.63

19.87

1.3

1.2

7.33

7.30

mmol/l

0.08

427

1303

Other disorders of amniotic fluid and membranes

200

959

2.04

19.48

1.7

1.4

6.48

6.70

mmol/l

0.82

191

869

Pregnancy hypertension

544

3192

1.54

19.37

1.5

1.4

6.87

6.77

mmol/l

0.43

492

2915

Care involving use of rehabilitation procedures

624

3786

1.49

19.36

1.3

7.47

7.15

mmol/l

1.79

522

3350

Any death

175

2467

0.49

19.32

1.2

8.08

7.56

mmol/l

1.45

155

2096

Caries of dentine, including avohilmo

676

2356

1.47

18.03

1.3

1.2

7.35

7.09

mmol/l

1.23

605

2053

Dental caries, including avohilmo

614

2102

1.50

18.02

1.3

1.2

7.35

7.16

mmol/l

0.80

550

1815

Perineal laceration during delivery

281

1282

1.79

17.96

1.6

1.5

6.20

6.49

mmol/l

1.93

265

1171

Sleep disorders (combined)

1088

4218

1.35

17.93

1.3

1.4

7.27

6.99

mmol/l

2.43

978

3734

Neurological diseases

911

3302

1.39

17.75

1.3

1.4

6.98

6.91

mmol/l

0.29

820

2929

Diabetic retinopathy

1414

0.40

17.67

1.2

1.3

10.04

9.27

mmol/l

0.98

1237

Bronchitis

1094

4915

1.34

17.43

1.4

1.3

7.07

7.04

mmol/l

0.12

1004

4334

Disorders of lipoprotein metabolism and other lipidaemias

711

3034

1.43

16.90

1.3

1.2

7.70

7.30

mmol/l

2.47

620

2644

Acute upper respiratory infections

1008

4493

1.35

16.86

1.4

1.3

7.14

7.08

mmol/l

0.28

909

3955

General examination and investigation of persons without complaint and reported diagnosis

658

2356

1.46

16.69

1.4

1.3

7.12

6.94

mmol/l

0.82

606

2096

Presence of other devices

203

1067

1.89

16.02

1.3

8.01

7.56

mmol/l

1.12

189

891

Obesity related asthma

349

2177

1.61

15.91

1.3

7.55

7.23

mmol/l

1.30

308

1920

Dental pulpitis, including avohilmo

993

4777

1.34

15.80

1.5

1.3

7.07

6.97

mmol/l

0.58

900

4273

Postpartum haemorrhage

343

1754

1.63

15.65

1.6

1.4

6.30

6.68

mmol/l

3.19

324

1590

Dental operations

471

1587

1.53

15.32

1.3

1.2

7.53

7.36

mmol/l

0.49

421

1373

Carpal tunnel syndrome

570

3438

1.44

15.13

1.4

1.3

7.39

7.21

mmol/l

0.77

512

3012

Pure hypercholesterolaemia

621

2786

1.42

14.44

1.2

7.60

7.36

mmol/l

1.02

558

2419

Diseases of pulp and periapical tissues, including avohilmo

1013

3986

1.32

14.22

1.4

1.3

7.24

6.96

mmol/l

2.17

895

3540

Headache

732

4156

1.37

13.96

1.4

1.3

7.07

6.97

mmol/l

0.42

663

3687

Diseases of pulp and periapical tissues and dental caries

525

1848

1.46

13.71

1.3

1.2

7.33

7.17

mmol/l

0.56

467

1592

Other abnormal products of conception

470

2096

1.48

13.70

1.7

1.4

6.51

6.64

mmol/l

0.60

425

1922

Other soft tissue disorders, not elsewhere classified

933

4031

1.32

13.53

1.4

7.05

6.97

mmol/l

0.37

832

3593

Haemorrhage in early pregnancy

300

1833

1.60

13.27

1.5

1.3

6.85

6.65

mmol/l

0.66

278

1668

Symptoms and signs involving the circulatory and respiratory systems

1045

4040

1.30

13.23

1.3

1.4

7.09

6.91

mmol/l

1.21

938

3610

Other dorsopathies, not elsewhere classified

1013

4056

1.30

13.00

1.4

7.08

6.97

mmol/l

0.53

913

3595

Spontaneous abortion

537

2541

1.42

12.77

1.5

1.4

6.84

6.80

mmol/l

0.13

487

2310

Fitting and adjustment of other devices

268

1461

1.62

12.45

1.2

8.07

7.63

mmol/l

1.24

220

1252

Parasetamol

759

2864

1.34

12.22

1.4

6.98

6.90

mmol/l

0.35

682

2533

Dorsopathies

1026

4061

1.28

11.84

1.4

7.07

6.97

mmol/l

0.50

931

3598

Failed induction of labour

110

541

2.08

11.39

1.9

1.5

6.60

6.55

mmol/l

0.09

103

498

Other and unspecified nerve root and plexus disorders, also in other diseases

214

1290

1.67

11.38

1.3

7.18

7.28

mmol/l

0.18

184

1149

Dorsalgia

978

4054

1.28

11.33

1.4

7.09

6.97

mmol/l

0.61

881

3593

Migraine

575

3283

1.37

11.24

1.4

6.74

6.78

mmol/l

0.14

531

2958

Procreative management

277

1458

1.57

11.21

1.5

1.2

6.94

7.36

mmol/l

1.68

256

1286

Metabolic disorders

833

3849

1.30

11.13

1.3

7.63

7.12

mmol/l

4.60

743

3395

Soft tissue disorders

1003

4043

1.27

11.02

1.4

7.03

6.97

mmol/l

0.25

899

3602

Hyperlipidaemia, other/unspecified

270

1560

1.56

10.81

1.3

1.2

8.17

7.56

mmol/l

2.03

214

1323

Asthma, including avohilmo

1129

4982

1.25

10.78

1.4

1.3

7.15

7.03

mmol/l

0.72

1030

4402

Antepartum haemorrhage, not elsewhere classified

117

601

1.98

10.70

1.8

1.4

6.68

6.79

mmol/l

0.20

108

548

Defect, injury or illness of lumbar spine

12.78

10.42

1.6

1.3

6.38

7.35

mmol/l

0.85

Angina pectoris

394

1814

1.45

10.38

1.2

7.65

7.60

mmol/l

0.10

327

1551

Asthma

772

3066

1.30

10.13

1.4

1.3

7.28

6.99

mmol/l

1.81

701

2674

Asthma (mode)

763

3084

1.30

10.11

1.4

1.3

7.27

7.00

mmol/l

1.67

695

2691

Speech therapy

214

1335

1.61

9.98

1.2

1.3

7.33

7.48

mmol/l

0.34

164

1169

Iron deficiency

267

2.46

9.97

1.7

1.5

6.36

6.45

mmol/l

0.11

245

Pregnancy with abortive outcome

699

2776

1.32

9.95

1.5

1.4

6.84

6.83

mmol/l

0.01

623

2486

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

777

3584

1.29

9.73

1.3

10.08

6.42

mmol/l

93.29

674

3167

Persons encountering health services in other circumstances

393

2765

1.41

9.69

1.4

7.07

6.95

mmol/l

0.34

367

2423

Maternal care for known or suspected fetal abnormality and damage

195

1015

1.64

9.49

1.7

1.4

6.13

6.74

mmol/l

4.45

180

923

Dentofacial anomalies [including malocclusion]

741

4524

1.29

9.47

1.4

6.68

6.98

mmol/l

2.51

662

4068

Placenta praevia

298

2.33

9.46

1.8

1.4

6.36

7.19

mmol/l

2.28

270

Asthma, excluding more controls

750

2985

1.29

9.40

1.4

1.3

7.27

6.96

mmol/l

2.11

684

2607

Provisional assignment of new diseases of uncertain etiology

499

3680

1.35

9.33

1.3

1.4

6.96

7.05

mmol/l

0.27

338

3307

Multiple delivery

351

2.19

9.28

1.4

1.2

6.70

7.87

mmol/l

3.69

315

Codes for special purposes

499

3684

1.35

9.27

1.3

1.4

6.96

7.05

mmol/l

0.27

338

3311

Lumbar disc prolapse

584

3276

1.32

9.26

1.3

7.33

7.18

mmol/l

0.60

520

2873

Maternal care for known or suspected disproportion

233

2.49

9.25

1.3

6.64

7.24

mmol/l

1.11

213

Obesity, other/unspecified

358

2530

1.42

9.22

1.4

1.3

7.38

6.87

mmol/l

3.06

321

2288

Other sleep disorders

116

625

1.87

9.22

1.3

1.4

6.99

7.12

mmol/l

0.19

111

562

Nerve, nerve root and plexus disorders

974

4709

1.24

9.17

1.4

1.3

7.35

7.05

mmol/l

2.44

870

4163

Migraine with aura

302

2074

1.47

9.08

1.4

1.5

6.84

6.68

mmol/l

0.50

278

1882

Percutaneous Coronary Intervention

588

2711

1.32

8.97

1.2

7.50

7.49

mmol/l

0.04

521

2350

Antihypertensive medication - note that there are other indications

683

2754

1.30

8.94

1.4

1.5

7.16

6.35

mmol/l

11.91

622

2482

Other intervertebral disc disorders

756

3535

1.28

8.92

1.3

7.23

7.09

mmol/l

0.62

670

3108

Coronary revascularization (ANGIO or CABG)

588

2711

1.32

8.90

1.2

7.52

7.49

mmol/l

0.09

522

2350

Diseases of oral cavity, salivary glands and jaws

414

1529

1.40

8.78

1.3

1.2

7.37

7.30

mmol/l

0.18

365

1303

1047

4315

1.23

8.76

1.4

1.3

7.21

7.05

mmol/l

0.93

947

3791

Flat foot [pes planus] (acquired)

502

1.95

8.74

1.2

1.3

7.38

7.32

mmol/l

0.07

442

Exposure to unspecified factor

638

5557

0.78

8.62

1.3

7.09

7.05

mmol/l

0.17

574

4930

Other retinal disorders

240

2713

0.67

8.57

1.2

1.3

7.52

7.44

mmol/l

0.15

203

2345

Contraceptive management

360

1788

1.41

8.54

1.3

1.2

7.00

7.30

mmol/l

1.24

329

1575

Ischemic heart diseases

630

2891

1.30

8.52

1.2

7.47

7.45

mmol/l

0.05

561

2512

Rotator cuff syndrome

489

2516

1.34

8.46

1.2

7.50

7.41

mmol/l

0.27

427

2186

Pain in joint

560

2622

1.32

8.31

1.4

1.3

7.12

7.06

mmol/l

0.21

506

2322

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

104

568

1.86

8.03

1.5

1.4

7.20

6.92

mmol/l

0.59

518

Emergency coronary revascularization (for ACS)

609

2852

1.29

7.91

1.2

7.53

7.50

mmol/l

0.06

539

2467

Twin gestation

106

587

1.83

7.82

1.5

1.3

6.41

6.88

mmol/l

1.44

526

Diseases of the respiratory system

617

2397

1.29

7.81

1.3

7.20

6.96

mmol/l

1.06

559

2086

Shoulder lesions

614

2867

1.29

7.71

1.2

1.3

7.55

7.30

mmol/l

1.13

525

2508

Statin medication

587

2560

1.29

7.65

1.2

1.4

7.79

6.64

mmol/l

14.48

531

2263

Spondylolisthesis/Spondylolysis

152

936

1.63

7.61

1.3

1.2

6.95

7.44

mmol/l

1.17

135

816

Major coronary heart disease event

612

2862

1.28

7.50

1.2

7.51

7.48

mmol/l

0.10

543

2481

Transient ischemic attack

334

1922

1.39

7.40

1.2

7.29

7.70

mmol/l

1.62

300

1620

Pain in limb

780

4000

1.24

7.38

1.4

7.08

6.97

mmol/l

0.52

684

3562

Artrosis, including avohilmo

690

3000

1.26

7.34

1.2

1.3

7.35

7.19

mmol/l

0.67

614

2638

Cholecystectomy

576

3834

1.28

7.31

1.4

1.3

7.66

7.19

mmol/l

3.31

491

3372

Multiple gestation

107

608

1.78

7.27

1.5

1.3

6.41

6.91

mmol/l

1.58

546

Gonarthrosis

496

2138

1.31

7.27

1.2

7.18

7.39

mmol/l

0.83

433

1856

Other pulmonary diagnosis

767

3090

1.25

7.22

1.3

7.23

6.99

mmol/l

1.29

691

2697

Retained placenta and membranes, without haemorrhage

128

767

1.69

7.19

1.5

1.3

6.73

6.99

mmol/l

0.52

117

680

Type of accident

263

1845

1.43

7.18

1.4

1.3

7.11

7.13

mmol/l

0.03

239

1635

Covid-19 confirmed case

300

2153

1.40

7.12

1.4

1.3

6.84

7.25

mmol/l

1.86

264

1918

Functional dyspepsia

243

1684

1.45

7.10

1.3

7.15

7.25

mmol/l

0.22

214

1487

Lyme disease

126

2051

0.61

7.07

1.3

7.18

7.34

mmol/l

0.20

106

1817

Lyme disease, including avohilmo

126

2051

0.61

7.07

1.3

7.18

7.34

mmol/l

0.20

106

1817

Spondylopathies

616

2881

1.27

6.90

1.3

7.43

7.32

mmol/l

0.38

558

2499

Disorders of the thyroid gland

883

4720

1.22

6.88

1.3

1.4

7.27

6.97

mmol/l

2.08

791

4193

Gingivitis and periodontal diseases

858

3628

1.22

6.87

1.3

7.27

7.06

mmol/l

1.19

758

3211

Other arthrosis

409

2062

1.33

6.84

1.2

7.23

7.42

mmol/l

0.63

368

1793

Spirochaetal infections, other/unspecified, including avohilmo

129

2068

0.62

6.80

1.3

7.19

7.33

mmol/l

0.17

109

1833

Rheumatism, unspecified

112

658

1.71

6.77

1.4

1.2

7.17

7.59

mmol/l

0.81

104

572

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

416

1979

1.33

6.76

1.4

1.3

7.17

6.89

mmol/l

1.07

381

1739

Pre-eclampsia or poor fetal growth

371

2776

1.34

6.69

1.6

1.5

6.43

6.71

mmol/l

1.77

341

2548

Leisure time condition

163

1055

1.56

6.68

1.4

7.07

7.12

mmol/l

0.06

145

943

Other spirochaetal diseases

130

2069

0.63

6.65

1.3

7.14

7.33

mmol/l

0.24

109

1832

Hard cardiovascular diseases

637

3005

1.26

6.61

1.2

7.47

7.39

mmol/l

0.25

574

2616

Persons encountering health services for examination and investigation

594

2356

1.27

6.52

1.3

6.98

6.94

mmol/l

0.10

528

2096

Exclusions for E4_PCOS_CONSORTIUM

497

3948

0.78

6.48

1.3

1.4

7.24

6.84

mmol/l

2.49

445

3556

Cardiovascular diseases

698

2991

1.24

6.47

1.4

6.91

6.58

mmol/l

2.58

640

2694

Heart failure and bmi 25plus

106

1180

0.60

6.46

1.2

8.25

7.69

mmol/l

1.00

964

Excluding asthma or asthma-COPD overlap

758

3090

1.23

6.46

1.3

7.22

6.99

mmol/l

1.25

687

2697

Other spirochaetal diseases, including avohilmo

134

2101

0.63

6.43

1.3

7.18

7.33

mmol/l

0.18

113

1863

Asthma (only as main-diagnosis)

680

3066

1.24

6.42

1.4

1.3

7.20

6.99

mmol/l

1.07

613

2674

Gonarthrosis,primary

631

3047

1.25

6.41

1.2

7.28

7.52

mmol/l

1.12

548

2635

Any event in cancer register

621

4497

0.80

6.38

1.3

1.4

7.30

6.99

mmol/l

1.76

567

3985

COPD differential diagnosis

756

3086

1.23

6.38

1.3

7.20

6.99

mmol/l

1.06

687

2693

Asthma (only as main-diagnosis), excluding more controls

670

2985

1.24

6.37

1.4

1.3

7.20

6.96

mmol/l

1.29

605

2607

Arthrosis

574

2491

1.27

6.33

1.2

1.3

7.38

7.27

mmol/l

0.37

503

2181

ILD differential diagnosis

755

3084

1.23

6.33

1.3

7.21

7.00

mmol/l

1.07

686

2691

Septicaemia

146

2040

0.65

6.27

1.2

1.3

7.48

7.43

mmol/l

0.08

125

1739

Preterm labour and delivery

234

1661

1.42

6.07

1.4

1.3

7.15

6.91

mmol/l

0.64

220

1492

Pain in throat and chest

787

3843

1.21

6.07

1.3

1.4

7.19

6.95

mmol/l

1.45

706

3422

Other blood glucose lowering drugs, excl. Insulins

587

0.34

6.05

1.2

8.92

6.83

mmol/l

0.88

503

Other septicaemia

126

1860

0.64

6.02

1.2

1.3

7.39

7.44

mmol/l

0.07

108

1582

Spinal stenosis

325

1786

1.34

5.94

1.2

7.67

7.68

mmol/l

0.03

288

1507

136

2.55

5.91

1.3

7.04

7.42

mmol/l

0.26

119

Disorders of choroid and retina

382

3466

0.77

5.88

1.2

1.3

7.46

7.40

mmol/l

0.15

316

3023

Hypothyroidism and >3 levothyroxin purchases

321

1336

1.35

5.80

1.4

1.5

7.09

6.15

mmol/l

6.51

294

1199

Hypothyroidism, levothyroxine purchases

321

1336

1.35

5.80

1.4

1.5

7.09

6.15

mmol/l

6.51

294

1199

Abnormalities of breathing

845

4036

1.20

5.73

1.3

1.4

7.26

6.91

mmol/l

2.87

751

3606

Malignant neoplasm

504

3694

0.80

5.70

1.2

1.3

7.39

7.17

mmol/l

0.91

454

3248

Mouth breathing

304

2272

1.34

5.69

1.2

1.3

7.16

7.30

mmol/l

0.37

271

1998

Pain (limb, back, neck, head abdominally)

647

2636

1.23

5.63

1.3

7.21

7.07

mmol/l

0.51

578

2333

Hypothyroidism (congenital or acquired)

320

1337

1.35

5.61

1.4

1.5

7.08

6.15

mmol/l

6.45

294

1200

General symptoms and signs

1019

4335

1.18

5.58

1.4

1.3

7.17

7.01

mmol/l

0.95

910

3848

Persons encountering health services for specific procedures, not carried out

501

0.32

5.57

1.4

7.78

7.04

mmol/l

0.26

451

Spondylosis

391

2365

1.29

5.56

1.2

7.32

7.49

mmol/l

0.51

353

2030

Ischaemic heart disease, wide definition

524

2576

1.25

5.55

1.2

7.55

mmol/l

0.00

455

2228

Malignant neoplasm of breast, including Hilmo

201

1820

0.70

5.54

1.2

1.3

7.41

7.24

mmol/l

0.34

183

1604

Malignant neoplasm of breast, HER2-negative, including Hilmo

201

1820

0.70

5.54

1.2

1.3

7.41

7.24

mmol/l

0.34

183

1604

Any operation in hilmo

2.61

5.49

1.3

1.1

7.89

7.03

mmol/l

0.74

Primary gonarthrosis, bilateral

329

2090

1.32

5.48

1.2

7.53

7.70

mmol/l

0.47

287

1786

Fall on same level

818

5187

0.84

5.47

1.3

7.13

7.02

mmol/l

0.47

735

4611

Malignant neoplasm

506

3689

0.80

5.47

1.2

1.3

7.39

7.18

mmol/l

0.87

456

3244

Complications predominantly related to the puerperium

304

2293

1.33

5.47

1.6

1.5

6.65

6.74

mmol/l

0.22

277

2089

Other diseases of pleura

138

1804

0.66

5.47

1.2

8.17

7.67

mmol/l

1.21

120

1529

Gonarthrosis [arthrosis of knee](FG)

572

2657

1.24

5.46

1.2

7.29

7.40

mmol/l

0.38

496

2310

Other enthesopathies

253

1854

1.37

5.46

1.3

7.52

7.27

mmol/l

0.63

227

1637

Familial hypercholesterolemia

516

1.71

5.44

1.2

8.07

7.73

mmol/l

0.38

435

Cholelithiasis

692

3903

1.21

5.41

1.3

7.77

7.10

mmol/l

6.65

590

3444

Malignant neoplasm of breast

195

1775

0.71

5.36

1.2

1.3

7.48

7.25

mmol/l

0.52

179

1561

Deforming dorsopathies

236

1716

1.38

5.35

1.3

7.08

7.18

mmol/l

0.19

211

1501

Solid cancers

494

3603

0.80

5.33

1.2

1.3

7.45

7.21

mmol/l

1.04

445

3162

Malignant neoplasm of breast, HER2-negative

195

1771

0.71

5.29

1.2

1.3

7.48

7.25

mmol/l

0.51

179

1557

Other diseases of upper respiratory tract

961

4258

1.18

5.23

1.3

7.12

7.10

mmol/l

0.07

856

3757

Triptan medication for migraine, single purchase ok

750

4247

1.20

5.21

1.4

6.94

mmol/l

0.02

683

3821

Migraine, single triptan purchase ok & required. ICD-code if available is included

750

4247

1.20

5.21

1.4

6.94

mmol/l

0.02

683

3821

Supplementary factors related to causes of morbidity and mortality classified elsewhere

272

2033

1.34

5.20

1.4

1.3

7.07

7.13

mmol/l

0.11

246

1808

Diseases of arteries, arterioles and capillaries

270

2639

0.75

5.20

1.2

7.95

7.49

mmol/l

1.63

232

2266

Other septicaemia, including avohilmo

136

1899

0.67

5.15

1.2

1.3

7.28

7.44

mmol/l

0.30

118

1616

Chronic diseases of tonsils and adenoids

748

3944

1.20

5.15

1.4

6.92

7.01

mmol/l

0.37

670

3517

COPD/asthma related infections

931

3962

1.18

5.12

1.4

1.3

7.17

7.01

mmol/l

0.92

847

3491

COPD/asthma/ILD related infections

931

3962

1.18

5.12

1.4

1.3

7.17

7.01

mmol/l

0.92

847

3491

Neurological diseases, wide definition

317

1202

1.33

5.07

1.4

1.5

6.85

6.18

mmol/l

4.49

285

1073

Special screening examination for neoplasms

293

1.93

5.06

1.2

7.94

7.57

mmol/l

0.28

257

Other joint disorders

865

3816

1.18

5.05

1.3

1.4

6.91

6.88

mmol/l

0.10

788

3412

Gastro-oesophageal reflux disease

555

3825

1.23

5.05

1.3

6.97

7.24

mmol/l

1.50

498

3349

Autoimmune diseases excluding thyroid diseases

709

4590

0.84

5.03

1.4

1.3

7.31

6.96

mmol/l

2.15

625

4081

Pilonidal cyst

524

1.67

4.94

1.4

7.08

6.82

mmol/l

0.45

479

Postpartum hemorraghe, all women as controls

343

2609

1.29

4.87

1.6

1.5

6.30

6.59

mmol/l

2.26

324

2393

Malignant neoplasm, including Hilmo

545

3868

0.82

4.86

1.2

1.3

7.32

7.15

mmol/l

0.72

491

3412

Cholelithiasis, broad definition with cholecystitis

713

3976

1.20

4.85

1.3

7.73

7.10

mmol/l

6.28

611

3512

Arthropathies

888

3818

1.18

4.84

1.3

1.4

7.00

6.88

mmol/l

0.59

801

3414

Thiazolidinediones

404

0.30

4.84

1.2

15.57

6.83

mmol/l

—

348

Hypothyroidism, other/unspecified

812

4527

1.18

4.80

1.3

1.4

7.34

6.95

mmol/l

3.02

728

4021

Disorders of synovium and tendon

475

3261

1.24

4.77

1.3

7.21

7.08

mmol/l

0.47

436

2885

Diseases of male genital organs

307

1173

1.32

4.77

1.1

7.45

7.59

mmol/l

0.30

271

1016

Malignant neoplasm, wide definition

545

3857

0.82

4.76

1.2

1.3

7.32

7.15

mmol/l

0.71

491

3403

Bacterial Sepsis

180

2075

0.71

4.75

1.2

7.96

7.50

mmol/l

1.11

158

1770

Autoimmune diseases excluding thyroid diseases, strict definition

695

4498

0.84

4.75

1.4

1.3

7.29

6.95

mmol/l

2.06

611

4000

Combinations of oral blood glucose lowering drugs

1293

0.61

4.71

1.1

1.2

11.17

6.75

mmol/l

7.89

1113

Factors influencing health status and contact with health services

208

749

1.40

4.63

1.3

1.1

7.13

7.35

mmol/l

0.54

186

642

Other obstructed labour

474

1.68

4.59

1.4

1.3

7.40

7.02

mmol/l

0.48

420

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

831

0.56

4.58

1.1

1.2

8.34

7.76

mmol/l

0.58

680

Benzodiazepine use

678

5422

0.84

4.56

1.3

1.4

7.47

6.99

mmol/l

3.96

622

4794

Insomnia

829

4926

1.17

4.56

1.3

1.4

6.92

7.04

mmol/l

0.66

765

4355

Other bacterial diseases

548

4380

0.83

4.53

1.3

7.60

7.16

mmol/l

2.77

477

3856

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

361

4336

0.79

4.49

1.4

6.67

6.91

mmol/l

1.18

340

3891

Diabetes, insulin treatment (Kela reimbursement)

797

4042

1.17

4.41

1.3

10.05

6.65

mmol/l

85.19

689

3571

L04AA Selective immunosuppressants

1405

0.64

4.41

1.3

7.32

7.18

mmol/l

0.18

1257

Explicit Sepsis

185

2305

0.73

4.40

1.3

7.18

7.33

mmol/l

0.32

162

1981

Sleep disorders

831

4905

1.17

4.39

1.3

1.4

6.95

7.05

mmol/l

0.51

763

4331

COPD, hospital admissions 3, with asthma pneumonia sepsis

886

0.58

4.37

1.3

1.2

8.06

7.87

mmol/l

0.17

737

Type 2 diabetes, wide definition

532

2767

1.21

4.30

1.3

1.2

9.94

6.53

mmol/l

56.17

463

2411

STROKE

417

2263

1.24

4.26

1.2

7.32

7.26

mmol/l

0.15

372

1978

Allergic conjunctivitis

380

4529

0.80

4.26

1.4

6.67

6.92

mmol/l

1.27

356

4064

Solid cancers, including Hilmo

535

3751

0.83

4.24

1.2

1.3

7.38

7.16

mmol/l

0.91

484

3304

Family history of other specific disorders

2.72

4.20

2.0

1.5

7.08

7.09

mmol/l

0.00

Substance abuse, excluding more controls

321

3385

0.79

4.20

1.3

7.49

7.04

mmol/l

1.78

291

2979

Allergic contact dermatitis

132

910

1.46

4.18

1.4

6.60

7.01

mmol/l

1.14

105

821

Cervical disc disorders

254

1950

1.31

4.12

1.3

1.2

7.63

7.46

mmol/l

0.36

231

1682

Renal tubulo-interstitial diseases

547

4785

0.84

4.11

1.3

1.4

7.50

7.03

mmol/l

3.17

485

4226

Cardiovascular diseases (excluding rheumatic etc)

667

3227

1.18

4.08

1.3

1.4

7.15

6.61

mmol/l

4.71

611

2902

COPD, hospital admission 2, with asthma infections

1149

0.64

4.08

1.3

1.2

7.77

7.85

mmol/l

0.09

960

Abdominal and pelvic pain

887

3846

1.16

4.08

1.3

7.25

7.08

mmol/l

0.89

778

3410

Cardiac arrhythmias

535

2848

1.21

4.08

1.2

1.3

7.02

6.31

mmol/l

7.95

491

2552

Malignant neoplasm of respiratory system and intrathoracic organs

708

0.56

3.97

1.1

1.2

8.29

7.74

mmol/l

0.44

586

Malignant neoplasm of digestive organs, including Hilmo

157

1595

0.72

3.96

1.2

7.90

7.59

mmol/l

0.59

140

1349

Pneumonias (Asthma/COPD co-morbidities)

690

5264

0.85

3.96

1.3

7.33

7.01

mmol/l

2.17

606

4679

Hypothyreosis and Thyroxine purchase for inclusion criteria

826

4675

1.16

3.94

1.3

1.4

7.33

6.95

mmol/l

2.88

739

4149

Infections of genitourinary tract in pregnancy

598

1.55

3.91

1.6

1.3

7.07

6.77

mmol/l

0.42

542

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

635

5025

0.85

3.90

1.3

7.23

7.08

mmol/l

0.66

562

4443

Gastrointestinal diseases

606

2554

1.19

3.90

1.4

6.96

6.83

mmol/l

0.56

552

2289

Poor fetal growth

181

1338

1.36

3.89

1.7

1.5

6.17

6.60

mmol/l

2.44

168

1235

Gonarthrosis, primary, with knee surgery

346

2156

1.25

3.88

1.2

7.42

7.70

mmol/l

1.02

291

1834

Varicose veins

416

2565

1.23

3.88

1.3

1.2

7.25

7.47

mmol/l

0.79

363

2221

Other noninflammatory disorders of cervix uteri

206

1.96

3.88

1.3

7.20

7.36

mmol/l

0.14

180

Disorders of lens

326

2528

0.80

3.85

1.2

7.38

7.50

mmol/l

0.31

283

2200

Sciatica+with lumbago

431

3137

1.22

3.85

1.3

7.13

7.17

mmol/l

0.11

386

2745

Lower back pain or/and sciatica

955

5192

1.14

3.82

1.3

7.13

7.03

mmol/l

0.47

849

4613

Chronic lower respiratory diseases

1080

5007

1.14

3.82

1.4

1.3

7.21

7.00

mmol/l

1.61

983

4432

Examination and encounter for administrative purposes

330

1.74

3.82

1.2

8.32

7.66

mmol/l

0.76

283

Exposure to other specified factors

540

5493

0.84

3.82

1.3

1.4

6.92

7.04

mmol/l

0.49

503

4868

Diseases of oesophagus, stomach and duodenum

922

4748

1.15

3.81

1.3

7.19

7.08

mmol/l

0.51

824

4200

Brachial plexus disorders

618

1.53

3.80

1.4

7.59

7.04

mmol/l

1.08

560

Explicit Sepsis, including avohilmo

196

2352

0.75

3.80

1.3

7.14

7.33

mmol/l

0.47

173

2025

Atherosclerosis, excluding cerebral and coronary sclerosis

114

1295

0.69

3.80

1.3

1.2

8.22

7.87

mmol/l

0.56

1066

All pneumoniae

699

5276

0.86

3.76

1.3

7.33

7.01

mmol/l

2.13

614

4692

Other specified/unspecified soft tissue disorders

188

1.99

3.73

1.4

1.3

7.35

7.55

mmol/l

0.15

163

Low back pain

695

4024

1.17

3.71

1.4

7.11

6.96

mmol/l

0.67

616

3565

Other headache syndromes

356

2880

1.24

3.68

1.3

1.4

6.98

6.96

mmol/l

0.05

329

2564

Malignant neoplasm of bronchus and lung, including Hilmo

706

0.58

3.68

1.1

1.2

8.34

7.76

mmol/l

0.58

580

Other appendicitis

426

1.63

3.66

1.4

1.3

6.98

7.20

mmol/l

0.28

377

Asthma (diagnoses ohter than nonallergic)

753

5265

1.16

3.65

1.3

7.19

7.02

mmol/l

0.88

687

4653

Covid-19 suspected case

208

1586

1.32

3.62

1.2

1.4

7.49

6.88

mmol/l

1.10

1461

Abnormalities of forces of labour

101

682

1.49

3.62

1.6

1.3

6.73

6.92

mmol/l

0.39

611

Acute nasopharyngitis (common cold)

105

709

1.48

3.60

1.2

1.3

6.61

7.17

mmol/l

1.42

633

Polycystic ovarian syndrome, broad definition

169

1256

1.36

3.55

1.7

1.6

6.84

6.46

mmol/l

1.43

152

1158

Sequelae of cerebrovascular disease

111

1356

0.70

3.53

1.3

1.2

7.52

7.78

mmol/l

0.33

1127

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

673

5190

0.86

3.51

1.3

7.34

7.01

mmol/l

2.16

592

4607

Cough

319

2399

1.24

3.51

1.3

6.98

7.13

mmol/l

0.43

277

2113

Other and unspecified tonsillitis

362

2456

1.23

3.50

1.4

6.77

6.72

mmol/l

0.14

335

2223

Bleeding

434

3650

0.83

3.49

1.2

1.3

7.67

7.32

mmol/l

1.39

368

3193

Asthma, hospital admissions , main diagnosis only

702

5282

1.16

3.49

1.4

1.3

7.20

7.01

mmol/l

0.92

632

4681

Fever of other and unknown origin

324

3456

0.81

3.48

1.3

7.22

7.09

mmol/l

0.38

287

3042

Substance abuse

321

3670

0.81

3.46

1.3

7.49

7.15

mmol/l

1.16

291

3244

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

101

690

1.48

3.45

1.6

1.4

6.51

6.86

mmol/l

0.82

625

Senile cataract

281

2142

0.80

3.45

1.2

7.48

7.57

mmol/l

0.19

245

1855

Behavioural syndromes associated with physiological disturbances and physical factors

838

4962

1.14

3.42

1.3

1.4

6.97

7.06

mmol/l

0.43

765

4381

Pre-eclampsia or eclampsia

213

1644

1.30

3.42

1.4

6.65

6.89

mmol/l

0.80

195

1494

Other hearing loss

157

1121

1.36

3.42

1.2

8.14

7.65

mmol/l

0.95

141

945

Lateral epicondylitis

109

757

1.45

3.40

1.2

7.26

7.42

mmol/l

0.21

667

Malignant neoplasm of digestive organs

138

1447

0.73

3.40

1.2

7.88

7.61

mmol/l

0.46

124

1222

Other cataract

179

1756

0.76

3.39

1.2

7.67

7.61

mmol/l

0.09

152

1509

Nonalcoholic fatty liver disease

538

1.53

3.39

1.4

1.3

8.17

7.33

mmol/l

1.19

483

First line medication for Crohn's disease

814

5000

0.87

3.38

1.4

1.3

7.13

6.99

mmol/l

0.70

738

4422

Dipeptidyl peptidase 4 (DPP-4) inhibitors

196

2001

0.77

3.37

1.2

10.89

6.76

mmol/l

22.46

162

1712

Care involving dialysis

315

0.35

3.35

1.1

1.3

8.32

7.32

mmol/l

0.47

274

309

3397

0.81

3.34

1.3

7.69

7.18

mmol/l

1.94

275

2995

Mental and behavioural disorders due to psychoactive substance use

335

3745

0.82

3.34

1.3

7.49

7.13

mmol/l

1.31

299

3314

Other female pelvic inflammatory diseases

141

1031

1.37

3.29

1.3

1.4

6.98

7.15

mmol/l

0.36

128

918

Malignant neoplasm of bronchus and lung

601

0.57

3.29

1.1

1.2

8.33

7.84

mmol/l

0.37

491

Enthesopathies of lower limb, excluding foot

182

1384

1.32

3.27

1.3

7.22

7.24

mmol/l

0.03

159

1224

Pre-eclampsia

203

1568

1.30

3.27

1.4

6.67

6.86

mmol/l

0.58

188

1423

Other/unspecified enthesopathies of lower limb, excluding foot

370

1.63

3.24

1.3

7.31

7.25

mmol/l

0.05

331

Disorders of muscles

544

1.52

3.23

1.4

1.3

6.85

7.34

mmol/l

0.83

479

Renal failure

165

1855

0.76

3.19

1.2

8.61

7.62

mmol/l

3.29

138

1561

Other neurological diseases

497

3268

1.18

3.18

1.3

7.25

7.37

mmol/l

0.37

444

2835

Extracorporeal dialysis

219

0.32

3.18

1.1

1.3

8.16

7.37

mmol/l

—

195

Presence of other functional implants

246

2117

0.79

3.16

1.2

7.75

7.54

mmol/l

0.41

200

1807

Medical abortion

593

2753

1.17

3.15

1.4

6.81

6.82

mmol/l

0.04

540

2466

Viral haemorrhagic fevers, not elsewhere classified/unspecified

373

1.62

3.15

1.3

7.76

7.18

mmol/l

0.84

333

Disorders of gallbladder, biliary tract and pancreas

801

4374

1.14

3.14

1.3

7.73

7.07

mmol/l

7.40

689

3868

Degenerative diseases of the nervous system

915

0.68

3.13

1.3

1.2

8.10

7.96

mmol/l

0.14

724

L02BA Anti-estrogens

855

0.62

3.13

1.3

1.2

7.97

7.45

mmol/l

0.55

745

Meniscus derangement

401

2215

1.20

3.11

1.2

7.19

7.31

mmol/l

0.32

358

1928

Malignant neoplasm of breast, ER-positive, including Hilmo

146

1453

0.74

3.10

1.2

1.3

7.52

7.40

mmol/l

0.20

132

1269

Glucagon-like peptide-1 (GLP-1) analogues

219

1721

1.28

3.09

1.3

1.2

9.48

6.58

mmol/l

22.80

187

1530

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

219

1721

1.28

3.09

1.3

1.2

9.48

6.58

mmol/l

22.80

187

1530

Lung cancer and mesothelioma

671

0.60

3.07

1.1

1.2

8.34

7.74

mmol/l

0.58

542

Malignant neoplasm of breast, HER-positive

146

1452

0.75

3.06

1.2

1.3

7.52

7.40

mmol/l

0.20

132

1268

Excessive earwax

446

3415

1.19

3.06

1.3

7.48

7.29

mmol/l

0.68

412

2951

KRA_PSY_EATING, excluding more controls

972

0.65

3.05

1.5

1.6

6.60

6.43

mmol/l

0.18

887

All chronic kidney diseases

256

2537

0.80

3.04

1.3

7.79

7.34

mmol/l

1.60

227

2193

Fracture of femur

942

0.66

3.04

1.3

1.2

7.64

7.80

mmol/l

0.18

780

Benign neoplasm: Colon, unspecified

151

1131

1.34

3.04

1.2

7.74

7.75

mmol/l

0.01

118

969

Leiomyoma of uterus

366

2470

0.83

3.03

1.3

7.44

7.13

mmol/l

1.24

317

2194

Diseases of inner ear

373

2973

1.20

3.03

1.3

7.23

7.41

mmol/l

0.59

321

2586

ILD medications: immunosuppressive drugs

410

4401

0.84

3.02

1.4

1.3

7.25

7.07

mmol/l

0.63

380

3872

Intrahepatic Cholestasis of Pregnancy (ICP)

628

1.46

3.01

1.7

1.5

6.33

6.78

mmol/l

1.41

578

ILD medications: prednisolone, methylprednisolone, prednisone

789

4971

0.88

3.00

1.3

7.22

6.99

mmol/l

1.43

715

4398

Oxycodone

158

1775

0.76

2.99

1.3

1.2

7.87

7.50

mmol/l

0.88

136

1483

Coeliac disease

687

1.43

2.96

1.6

1.4

6.99

7.14

mmol/l

0.22

621

Abrasion of teeth

295

2412

1.23

2.95

1.3

6.93

7.25

mmol/l

1.14

262

2152

Malignant neoplasm of skin

220

1877

0.79

2.93

1.2

7.77

7.51

mmol/l

0.62

193

1607

Reimbursement for rheumatic diseases

308

3709

0.82

2.92

1.3

7.21

7.17

mmol/l

0.09

279

3261

Dental caries

171

1236

1.31

2.92

1.3

7.50

7.20

mmol/l

0.61

145

1062

Pneumonia, organism unspecified

606

4774

0.87

2.92

1.3

7.42

7.06

mmol/l

2.28

532

4222

Inflammatory diseases of prostate (prostatitis)

484

1.51

2.92

1.2

7.16

7.60

mmol/l

0.72

419

Alzheimer disease, including avohilmo

860

0.69

2.92

1.3

1.2

8.10

8.04

mmol/l

0.06

665

Peripheral artery disease

138

1455

0.75

2.91

1.3

1.2

8.54

7.81

mmol/l

1.74

117

1202

Hyperplasia of prostate

211

928

1.28

2.89

1.1

7.66

7.65

mmol/l

0.02

184

795

Puerperal sepsis

107

766

1.40

2.89

1.4

1.3

6.89

7.23

mmol/l

0.74

686

Diseases of the musculoskeletal system and connective tissue

536

2303

1.17

2.89

1.4

6.84

6.85

mmol/l

0.04

487

2058

Intussusception

102

2.19

2.89

1.4

6.74

7.64

mmol/l

1.33

Implicit bacterial Sepsis

157

1760

0.76

2.88

1.2

8.09

7.60

mmol/l

1.06

139

1482

Hernia of abdominal wall

322

2664

1.21

2.87

1.3

7.40

7.35

mmol/l

0.13

284

2312

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

131

1748

0.75

2.84

1.4

1.5

6.67

6.72

mmol/l

0.08

124

1585

Labour and delivery complicated by umbilical cord complications

314

1.64

2.83

1.4

7.22

7.12

mmol/l

0.13

278

Other contact dermatitis

473

1.51

2.80

1.6

1.4

6.51

7.05

mmol/l

0.89

434

336

3497

0.83

2.78

1.3

7.73

7.16

mmol/l

2.49

300

3086

Neuralgia and neuritis, unspecified

239

1.73

2.78

1.3

7.30

7.45

mmol/l

0.09

210

Hand

3.36

2.77

1.7

1.6

9.20

7.13

mmol/l

0.58

Malignant neoplasm of tongue

0.00

2.77

0.0

1.2

—

7.59

—

Basal cell carcinoma, including Hilmo

189

1629

0.78

2.76

1.2

7.86

7.58

mmol/l

0.60

163

1379

Rheumatoid arthritis, including avohilmo

167

2149

0.78

2.75

1.3

7.64

7.36

mmol/l

0.51

146

1884

Malignant neoplasm of skin, including Hilmo

243

2013

0.81

2.75

1.2

7.76

7.49

mmol/l

0.64

214

1724

Mood [affective] disorders

892

5098

1.12

2.75

1.3

7.21

7.02

mmol/l

1.17

811

4509

Bacterial infection, other or unspecified

247

2563

0.81

2.72

1.2

1.3

8.03

7.36

mmol/l

2.46

209

2206

Mood disorders

893

5099

1.12

2.71

1.3

7.22

7.02

mmol/l

1.21

812

4509

Other diseases of the respiratory system

800

0.64

2.71

1.2

8.23

7.58

mmol/l

0.81

682

Other respiratory disorders and diseases

800

0.64

2.71

1.2

8.23

7.58

mmol/l

0.81

682

Tonsillectomy and adenotomy

581

3518

1.15

2.71

1.5

1.4

6.56

6.80

mmol/l

1.61

532

3198

Influenza and pneumonia

766

5320

0.89

2.69

1.3

7.23

6.99

mmol/l

1.50

681

4732

Metatarsalgia

536

1.46

2.66

1.4

1.3

7.60

7.46

mmol/l

0.16

468

Disorders of vestibular function (Vertigo)

312

2526

1.21

2.66

1.3

7.26

7.44

mmol/l

0.53

270

2192

Other enthesopathy of foot (+metatarsalgia)

594

1.44

2.65

1.4

1.3

7.53

7.37

mmol/l

0.20

517

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

253

1.58

2.65

1.2

7.05

6.56

mmol/l

0.77

208

Acne, including avohilmo

194

1974

0.79

2.64

1.5

1.6

6.38

6.39

mmol/l

0.03

184

1813

Infections with a predominantly sexual mode of transmission

219

2705

0.81

2.63

1.4

7.09

6.70

mmol/l

1.36

205

2458

Infective dermatitis

604

1.43

2.62

1.3

7.01

7.29

mmol/l

0.45

548

Diverticular disease of intestine

484

2591

1.16

2.61

1.2

7.42

7.54

mmol/l

0.39

401

2248

Depression

844

5039

1.12

2.60

1.3

7.14

7.01

mmol/l

0.70

775

4468

Other/unspecified dorsalgia

296

2425

1.21

2.60

1.4

1.3

7.02

7.11

mmol/l

0.25

263

2127

Obstructed labour due to maternal pelvic abnormality

109

799

1.37

2.59

1.5

1.3

7.41

7.27

mmol/l

0.21

102

714

Examination and observation for other reasons

351

2353

0.84

2.59

1.3

7.14

6.94

mmol/l

0.73

313

2093

Other medical care

208

2173

0.80

2.59

1.3

7.86

7.39

mmol/l

1.57

190

1892

Dermatitis and eczema

960

5109

1.11

2.58

1.4

1.3

6.86

7.10

mmol/l

2.01

850

4540

Alcohol use disorder, Swedish definition

288

3150

0.83

2.58

1.2

1.3

7.74

7.23

mmol/l

1.90

264

2768

Diseases of the skin and subcutaneous tissue

878

3938

1.12

2.56

1.4

1.3

7.25

7.03

mmol/l

1.32

784

3507

Acute tubulo-interstitial nephritis

375

3719

0.85

2.54

1.3

1.4

7.40

7.06

mmol/l

1.35

333

3274

Hypothyroidism, drug reimbursement

140

741

1.32

2.54

1.3

1.4

7.11

6.29

mmol/l

3.46

123

661

Other anaemias

165

1967

0.78

2.53

1.2

7.57

7.56

mmol/l

0.01

136

1677

Mental and behavioural disorders due to alcohol

279

3199

0.83

2.53

1.3

7.53

7.18

mmol/l

1.10

247

2821

Heart failure, not strict

363

2875

0.85

2.50

1.2

7.72

7.44

mmol/l

0.93

320

2474

Other and unspecified anaemias

163

1948

0.78

2.50

1.2

7.56

7.57

mmol/l

0.02

135

1659

Benign neoplasm: Colon

322

2535

1.19

2.49

1.2

7.63

7.62

mmol/l

0.02

266

2184

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

686

1.39

2.49

1.2

1.3

6.76

7.36

mmol/l

1.44

611

Hypothyroidism, strict autoimmune

683

3966

1.13

2.48

1.3

1.4

7.34

6.91

mmol/l

2.86

606

3529

Nausea and vomiting

125

1603

0.76

2.48

1.4

7.11

mmol/l

0.00

105

1414

Convergence insufficiency and excess

2.18

2.47

1.7

1.5

5.63

7.31

mmol/l

4.32

Cerebrovascular diseases (FINNGEN)

222

1255

1.24

2.47

1.3

1.2

7.54

7.10

mmol/l

1.03

198

1089

Umbilical hernia

206

1658

1.25

2.46

1.3

7.29

7.28

mmol/l

0.01

180

1440

Other heart diseases

388

2145

1.18

2.45

1.2

1.3

7.19

6.84

mmol/l

1.49

357

1896

Inflammatory disorders of breast

563

1.43

2.45

1.7

1.6

6.29

6.74

mmol/l

1.48

508

Impacted maxillary molar

580

1.43

2.44

1.5

1.6

6.17

6.48

mmol/l

0.82

537

Symptoms and signs involving the digestive system and abdomen

857

3846

1.12

2.44

1.3

7.17

7.08

mmol/l

0.37

761

3410

Malignant neoplasm of other and unspecified parts of tongue

0.00

2.44

0.0

1.2

—

7.83

—

Other degenerative diseases of the nervous system

105

1032

0.74

2.42

1.4

1.3

7.15

7.49

mmol/l

0.58

881

severe traumatic brain injury, does not include concussion

945

0.69

2.42

1.4

1.2

7.47

7.64

mmol/l

0.19

801

Arthropod-borne viral fevers and viral haemorrhagic fevers

473

1.47

2.42

1.3

7.47

7.24

mmol/l

0.28

421

All-cause Heart Failure

213

1827

0.81

2.41

1.2

8.45

7.64

mmol/l

2.77

188

1529

Unspecified fall

270

3182

0.83

2.40

1.3

7.12

7.23

mmol/l

0.24

235

2788

Other and unspecified haemorrhagic conditions

0.00

2.40

0.0

1.4

—

7.54

—

Other disorders of binocular vision

2.25

2.40

2.0

1.5

6.31

7.50

mmol/l

1.88

Other bacterial diseases, including avohilmo

680

4772

0.89

2.39

1.3

7.56

7.05

mmol/l

4.11

606

4215

Glomerular diseases

895

0.68

2.39

1.3

7.47

7.43

mmol/l

0.04

791

Implicit Sepsis, including avohilmo

507

4143

0.87

2.39

1.3

7.43

7.18

mmol/l

1.12

454

3628

Organic, including symptomatic, mental disorders

177

1564

0.79

2.38

1.2

7.91

7.82

mmol/l

0.13

150

1300

Infections with a predominantly sexual mode of transmission, including avohilmo

317

3429

0.84

2.38

1.5

6.89

6.67

mmol/l

0.79

300

3121

Disturbances of skin sensation

252

2081

1.21

2.37

1.4

6.57

7.05

mmol/l

2.17

222

1874

COPD, hospital admissions 1, only main diagnosis

104

1199

0.74

2.37

1.3

1.2

7.87

7.81

mmol/l

0.06

1009

Iridocyclitis

101

1358

0.74

2.36

1.3

7.12

7.25

mmol/l

0.20

1216

Unspecific neurodegenerative disorder

110

1005

0.75

2.36

1.2

7.87

8.06

mmol/l

0.24

800

Other, unspecified and serous retinal detachments

118

1.97

2.36

1.3

1.2

7.28

7.55

mmol/l

0.19

101

Condition for Implicit Sepsis (Organ dysfunction codes)

539

4251

0.88

2.36

1.3

7.41

7.16

mmol/l

1.18

483

3738

Any reimbursement code in KELA

628

2775

1.14

2.35

1.4

7.34

6.27

mmol/l

15.46

576

2487

Pedal cyclist injured in transport accident

114

1505

0.76

2.35

1.3

1.4

6.89

7.06

mmol/l

0.30

1356

Other malignant neoplasms of skin (=non-melanoma skin cancer)

190

1603

0.80

2.33

1.1

1.2

7.88

7.64

mmol/l

0.49

165

1353

Fall on same level involving ice and snow

452

3926

1.15

2.31

1.3

7.08

7.15

mmol/l

0.18

391

3475

Viral warts, including avohilmo

121

1579

0.76

2.30

1.3

1.4

6.84

6.92

mmol/l

0.13

111

1419

Anterior Iridocyclitis

1156

0.72

2.30

1.3

7.09

7.23

mmol/l

0.19

1032

Polycystic ovarian syndrome

630

1.39

2.30

1.8

1.6

6.93

6.53

mmol/l

0.85

580

Lactose intolerance

148

1.84

2.29

1.4

1.5

6.93

7.28

mmol/l

0.32

132

Persons encountering health services for specific procedures and health care

926

4940

1.11

2.29

1.3

1.4

7.40

6.95

mmol/l

4.63

811

4417

Other disorders of eyelid

261

2046

1.21

2.28

1.3

1.2

7.57

7.59

mmol/l

0.04

219

1752

Alzheimer disease

746

0.71

2.28

1.3

1.2

8.06

8.01

mmol/l

0.05

577

372

3166

1.17

2.27

1.4

7.16

7.00

mmol/l

0.49

333

2815

Polypectomy (DHB20)

270

1.60

2.26

1.1

1.3

8.57

7.25

mmol/l

1.31

238

Cerebrovascular diseases

350

2839

0.85

2.25

1.3

1.2

7.62

7.54

mmol/l

0.17

305

2442

Other specific joint derangements/joint disorders

683

3791

1.12

2.25

1.4

7.13

6.88

mmol/l

1.45

623

3394

Acute and subacute iridocyclitis

1092

0.72

2.23

1.3

7.19

7.25

mmol/l

0.07

979

Ganglion

178

1428

1.25

2.23

1.3

7.26

7.11

mmol/l

0.27

170

1278

Anogenital herpesviral [herpes simplex] infection, including avohilmo

1032

0.71

2.22

1.4

1.5

6.64

6.71

mmol/l

0.09

942

Asthma/COPD (KELA code 203)

831

5006

1.11

2.22

1.4

1.3

7.15

7.00

mmol/l

0.79

753

4431

Allergic asthma (mode), excluding more controls

223

1788

1.22

2.22

1.5

1.4

6.76

6.71

mmol/l

0.10

205

1581

Malignant neoplasm of colon, including Hilmo

758

0.67

2.21

1.2

7.87

7.78

mmol/l

0.08

626

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

366

1565

1.18

2.21

1.3

1.4

6.99

6.83

mmol/l

0.49

330

1404

Thoracic aortic aneurysm

616

0.63

2.21

1.1

1.2

7.38

7.73

mmol/l

0.41

523

Abnormalities of heart beat

271

2201

1.20

2.20

1.3

1.4

7.34

7.09

mmol/l

0.62

235

1943

Heart failure, strict

220

1859

0.82

2.20

1.2

8.43

7.62

mmol/l

2.79

193

1559

Malignant neoplasm of breast, ER-negative, including Hilmo

1041

0.73

2.20

1.2

1.3

7.17

7.48

mmol/l

0.42

894

Other symptoms and signs involving the nervous and musculoskeletal systems

325

2767

1.18

2.20

1.3

7.27

7.15

mmol/l

0.30

291

2451

Migraine with aura and triptan purchases

185

1495

1.24

2.19

1.4

1.5

6.93

6.64

mmol/l

0.68

168

1367

Second line medication for Crohn's disease

344

4004

0.86

2.19

1.4

1.3

7.30

7.11

mmol/l

0.55

316

3547

Allergic asthma (mode)

223

1792

1.22

2.18

1.5

1.4

6.76

6.71

mmol/l

0.09

205

1591

Other symptoms and signs involving the digestive system and abdomen

124

954

1.30

2.18

1.3

7.19

7.24

mmol/l

0.06

115

848

Kidney transplant status

214

0.42

2.18

1.2

1.3

7.71

7.39

mmol/l

—

189

Heart failure,strict

208

1772

0.82

2.18

1.2

8.43

7.63

mmol/l

2.64

185

1488

Benign paroxysmal vertigo

190

1540

1.24

2.17

1.3

7.15

7.53

mmol/l

1.09

162

1334

Malignant neoplasm of breast, HER-negative

954

0.71

2.17

1.2

1.3

7.35

7.52

mmol/l

0.18

814

Bacterial pneumoniae

195

2098

0.81

2.17

1.3

7.48

7.33

mmol/l

0.29

169

1802

Abnormal findings on examination of urine, without diagnosis

181

1.73

2.15

1.3

1.4

8.15

7.39

mmol/l

0.80

157

All kidney diseases

703

5244

0.90

2.15

1.3

7.41

6.98

mmol/l

3.46

628

4661

Female infertility, associated with anovulation

127

984

1.30

2.15

1.7

1.6

6.82

6.35

mmol/l

1.86

115

907

Bacterial infection, other or unspecified, including avohilmo

293

2831

0.85

2.14

1.3

7.92

7.31

mmol/l

2.19

254

2444

Sulfasalazine

150

1886

0.79

2.14

1.4

1.3

7.17

7.22

mmol/l

0.06

141

1666

Eating disorder

905

0.70

2.13

1.5

1.6

6.60

6.53

mmol/l

0.06

835

Non-allergic asthma (mode)

142

1105

1.28

2.13

1.4

1.3

7.44

7.07

mmol/l

0.75

125

948

Implicit bacterial Sepsis, including avohilmo

192

1957

0.81

2.13

1.3

1.2

7.92

7.56

mmol/l

0.81

171

1662

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

207

1700

0.82

2.11

1.2

7.76

7.60

mmol/l

0.33

180

1444

Basal cell carcinoma

184

1543

0.81

2.08

1.1

1.2

7.90

7.62

mmol/l

0.57

156

1300

Non-allergic asthma (mode), excluding more controls

142

1109

1.27

2.08

1.4

1.3

7.44

7.09

mmol/l

0.69

125

950

Temporomandibular joint disorders, including avohilmo

454

3856

1.14

2.08

1.4

6.64

6.81

mmol/l

0.77

410

3510

Generalized anxiety disorder

122

1562

0.78

2.07

1.3

1.5

6.73

6.59

mmol/l

0.22

113

1423

Mycoses

139

1755

0.79

2.07

1.3

7.00

7.26

mmol/l

0.59

121

1567

Benign thyroid growths and nodules

213

1632

1.22

2.06

1.3

7.07

7.32

mmol/l

0.72

191

1423

Coxarthrosis

311

1705

1.18

2.05

1.2

7.82

7.55

mmol/l

0.82

254

1471

Hypothyroidism, strict autoimmune, 3 medication purchases required

731

4422

1.11

2.04

1.3

1.4

7.34

6.94

mmol/l

2.81

652

3928

Other condition

109

833

1.31

2.04

1.4

1.3

7.14

mmol/l

0.01

101

748

Atrial fibrillation and flutter

202

1065

1.23

2.03

1.2

7.64

7.17

mmol/l

1.32

188

911

Fracture of rib(s), sternum and thoracic spine

126

1606

0.78

2.03

1.2

7.53

7.51

mmol/l

0.02

108

1387

Use of hypnotics and sedatives

736

4660

0.90

2.03

1.2

1.3

7.33

7.10

mmol/l

1.09

659

4113

Other (seronegative) rheumatoid arthritis, wide

968

0.72

2.02

1.3

7.75

7.49

mmol/l

0.22

846

Malignant neoplasm of oral cavity, including Hilmo

162

0.37

2.01

1.2

5.93

7.58

mmol/l

—

140

Recurrent or chronic depression

379

2276

1.16

2.01

1.3

1.4

7.06

6.95

mmol/l

0.32

347

2024

Dialysis

147

0.34

2.01

1.2

1.3

7.84

7.47

mmol/l

—

127

Dementia

126

1099

0.78

1.99

1.2

8.04

8.00

mmol/l

0.05

105

886

Other and unspecified disorders of vitreous body

257

2118

1.19

1.99

1.2

7.10

7.61

mmol/l

2.20

215

1830

Mental and behavioural disorders due to alcohol, excluding acute intoxication

231

2731

0.84

1.98

1.2

1.3

7.49

7.29

mmol/l

0.47

210

2389

Myocarditis

201

1.65

1.98

1.4

1.3

6.68

7.36

mmol/l

0.85

175

Coronary atherosclerosis

383

2093

1.16

1.97

1.2

7.66

7.60

mmol/l

0.14

337

1796

Conjunctivitis

553

4988

0.89

1.97

1.4

6.84

6.98

mmol/l

0.59

518

4445

Caries of dentine

145

1113

1.26

1.97

1.3

1.2

7.38

7.23

mmol/l

0.22

120

950

Acute alcohol intoxication, ICD10

1283

0.76

1.96

1.3

7.51

7.14

mmol/l

0.48

1155

Inflammatory disease of uterus

153

1228

1.25

1.96

1.7

1.5

7.25

6.78

mmol/l

1.19

144

1119

Budesonide

927

0.72

1.95

1.4

7.23

7.08

mmol/l

0.16

829

Spirochaetal infections, other/unspecified

412

0.58

1.95

1.2

1.3

7.59

7.42

mmol/l

0.04

364

Osteoporosis

1053

0.75

1.95

1.2

6.91

7.74

mmol/l

1.95

888

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1099

0.75

1.95

1.2

8.13

7.65

mmol/l

0.90

915

Malignant neoplasm of head and neck

309

0.52

1.94

1.1

1.2

7.12

7.61

mmol/l

0.20

259

IBD patients in KELA-register

125

1584

0.79

1.94

1.4

6.97

6.98

mmol/l

0.02

110

1428

Acute pharyngitis

145

1146

1.26

1.94

1.5

1.4

7.13

6.79

mmol/l

0.98

137

1039

Inflammatory bowel disease

176

2148

0.82

1.94

1.4

1.3

7.05

7.10

mmol/l

0.10

157

1923

Alcohol use disorder, ICD-based

214

2562

0.83

1.92

1.2

1.3

7.47

7.28

mmol/l

0.39

195

2233

Coxarthrosis, primary, with hip surgery

245

1912

1.19

1.92

1.2

7.71

7.72

mmol/l

0.01

202

1617

Fracture of forearm

331

3436

0.86

1.92

1.3

6.65

7.17

mmol/l

3.43

293

3054

Other abnormal findings in urine

2.27

1.92

1.2

1.4

7.94

7.39

mmol/l

—

Bacterial pneumonia (organism specified)

205

2231

0.83

1.92

1.3

7.47

7.37

mmol/l

0.19

176

1929

Follow-up examination after treatment for conditions other than malignant neoplasms

367

2119

1.15

1.91

1.4

6.84

6.89

mmol/l

0.15

323

1890

Inflammatory bowel disease, strict (require KELA)

125

1580

0.79

1.91

1.4

6.97

6.99

mmol/l

0.03

110

1427

Candidiasis, including avohilmo

189

2284

0.83

1.89

1.3

1.4

7.03

6.98

mmol/l

0.12

175

2036

Amenorrhoea

710

0.69

1.89

1.4

1.6

7.05

6.37

mmol/l

1.16

650

Other or unspecified ileus, impaction or obstruction

804

0.71

1.88

1.2

7.19

7.71

mmol/l

0.77

693

Nontraumatic intracranial haemmorrhage

804

0.71

1.88

1.2

7.80

7.73

mmol/l

0.05

682

Liquid cancers

108

1312

0.78

1.87

1.2

7.54

7.51

mmol/l

0.04

1113

Lichen planus

576

1.36

1.87

1.2

7.46

7.48

mmol/l

0.03

502

Lactose intolerance, other/unspecified

129

1.80

1.86

1.4

1.5

7.09

7.33

mmol/l

0.18

116

Seropositive rheumatoid arthritis, wide

109

1396

0.78

1.86

1.3

7.41

7.50

mmol/l

0.11

1216

Other and unspecified vascular occlusions

325

1.48

1.85

1.3

1.2

8.40

7.77

mmol/l

0.68

273

Intestinal stricture

118

1496

0.79

1.85

1.3

1.2

6.97

7.60

mmol/l

1.97

105

1291

Implicit Sepsis

441

3674

0.88

1.84

1.3

7.47

7.24

mmol/l

0.95

392

3211

Any dementia, excluding more controls

100

891

0.77

1.84

1.3

1.2

7.99

7.94

mmol/l

0.06

710

Crushed, pushed or stepped on by crowd or human stampede

441

0.61

1.83

1.4

6.85

6.79

mmol/l

0.05

402

Osteomyelitis

262

0.49

1.81

1.3

7.81

7.56

mmol/l

0.08

229

Nontoxic multinodular goitre

113

884

1.28

1.81

1.3

1.2

6.99

7.48

mmol/l

1.37

100

757

Eating disorders

980

0.74

1.81

1.4

1.6

6.63

6.56

mmol/l

0.07

902

Autoimmune diseases related-to ILD

583

5407

0.90

1.81

1.4

1.3

7.20

7.05

mmol/l

0.64

515

4803

N06DA Anticholinesterases

892

0.76

1.80

1.2

7.96

8.07

mmol/l

0.11

701

Use of anticholinesterases

892

0.76

1.80

1.2

7.96

8.07

mmol/l

0.11

701

Pedal cyclist injured in noncollision transport accidents

680

0.69

1.80

1.2

1.3

6.90

7.03

mmol/l

0.12

618

Disorders of mineral metabolism

344

1.46

1.80

1.2

1.3

7.46

7.39

mmol/l

0.06

306

Other/unspecified seropositive rheumatoid arthritis

108

1377

0.78

1.79

1.3

7.43

7.50

mmol/l

0.09

1199

Oedema, not elsewhere classified

225

1851

1.19

1.79

1.4

1.3

7.53

7.35

mmol/l

0.36

188

1586

Any dementia

110

971

0.78

1.79

1.3

1.2

7.99

8.03

mmol/l

0.04

764

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

107

1364

0.78

1.78

1.3

7.40

7.48

mmol/l

0.10

1187

5-aminosalicylic acid

116

1464

0.79

1.77

1.3

6.71

7.06

mmol/l

0.86

103

1302

Explicit bacterial Sepsis

498

0.64

1.76

1.3

7.80

7.35

mmol/l

0.31

433

Diaphragmatic hernia

211

1771

1.19

1.76

1.3

1.2

7.37

7.57

mmol/l

0.55

190

1504

Contracture of muscle

3.41

1.76

1.2

1.3

6.68

7.34

mmol/l

—

Noninfective enteritis and colitis

269

3126

0.86

1.75

1.4

1.3

7.20

7.11

mmol/l

0.22

238

2773

Endocarditis

136

0.37

1.75

1.2

1.3

8.42

7.55

mmol/l

—

120

Benign neoplasm of colon, rectum, anus and anal canal

380

2818

1.14

1.75

1.2

7.54

7.56

mmol/l

0.05

313

2437

Vitreous haemorrhage

436

0.62

1.75

1.2

8.94

7.42

mmol/l

1.34

377

Other diseases of intestine

734

0.71

1.74

1.2

7.05

7.67

mmol/l

0.79

639

Periodontitis

785

4562

1.10

1.74

1.3

7.49

7.10

mmol/l

2.64

671

4047

Bacterial pneumonia, not elsewhere classified

186

1960

0.83

1.74

1.3

7.44

7.33

mmol/l

0.22

162

1684

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

355

1.44

1.74

1.3

7.16

7.22

mmol/l

0.05

311

Injuries to the elbow and forearm

478

4586

0.89

1.73

1.3

6.87

7.06

mmol/l

0.87

423

4072

Diseases of external ear

184

2207

0.83

1.73

1.3

7.38

7.27

mmol/l

0.19

162

1941

Periapical abscess

352

3083

1.14

1.72

1.3

7.53

7.22

mmol/l

0.99

305

2732

Disorders of conjunctiva

608

5205

0.90

1.72

1.4

6.91

7.01

mmol/l

0.38

558

4618

Ankylosing hyperostosis [Forestier]

2.32

1.71

1.1

1.2

8.31

7.83

mmol/l

0.22

Medicines for HER+ breast cancer

171

1921

0.83

1.71

1.3

7.48

7.36

mmol/l

0.21

154

1677

Acute alcohol intoxication

120

1500

0.80

1.70

1.3

7.63

7.20

mmol/l

0.71

102

1330

Pain in thoracic spine

122

974

1.26

1.68

1.4

1.3

7.01

7.17

mmol/l

0.28

116

864

Mood disorders, excluding more controls

807

4337

1.09

1.68

1.3

7.28

7.02

mmol/l

1.76

734

3821

Diseases of the ear and mastoid process

1009

4664

1.08

1.68

1.3

1.4

7.11

6.99

mmol/l

0.69

903

4177

COPD related to multimorbidity

134

1398

0.81

1.68

1.3

1.2

7.95

7.83

mmol/l

0.16

115

1170

Diseases of tongue

251

1.52

1.67

1.2

1.3

6.44

7.43

mmol/l

1.56

217

Benign neoplasm: Adrenal gland

333

1.45

1.67

1.2

1.3

7.55

7.51

mmol/l

0.03

292

Nontoxic goitre/thyroid nodule

179

1489

1.20

1.67

1.3

7.12

7.44

mmol/l

0.87

160

1294

Female infertility, cervical, vaginal, other or unspecified origin

311

1725

1.16

1.67

1.5

6.73

6.59

mmol/l

0.53

283

1583

Asthma, hospital admission 2, infections

452

3928

1.12

1.66

1.4

1.3

7.25

7.04

mmol/l

0.76

405

3454

Asthma-related infections

452

3928

1.12

1.66

1.4

1.3

7.25

7.04

mmol/l

0.76

405

3454

Lower leg

2.85

1.66

1.3

8.00

7.38

mmol/l

—

Chronic periodontitis, including avohilmo

782

4562

1.09

1.66

1.3

7.48

7.10

mmol/l

2.51

667

4047

Other benign neoplasms of connective and other soft tissue

460

1.38

1.65

1.4

1.3

6.93

7.30

mmol/l

0.53

408

Benign lipomatous neoplasm

190

1591

1.20

1.65

1.2

1.3

6.80

7.43

mmol/l

2.87

170

1387

L04AX Other immunosuppressants

334

3804

0.88

1.65

1.4

1.3

7.32

7.13

mmol/l

0.53

309

3368

Necrosis of pulp, including avohilmo

510

4526

1.11

1.65

1.4

1.3

7.43

7.00

mmol/l

2.16

447

4047

Special screening examination for infectious and parasitic diseases

188

1636

0.84

1.65

1.4

6.71

6.69

mmol/l

0.05

179

1496

Other diseases of blood and blood-forming organs, wide

1169

0.78

1.64

1.4

1.3

7.75

7.39

mmol/l

0.48

1036

Other shoulder lesions

521

1.35

1.63

1.4

1.3

7.51

7.30

mmol/l

0.20

459

Symptoms and signs involving the skin and subcutaneous tissue

576

4917

1.11

1.63

1.4

1.3

6.95

7.09

mmol/l

0.58

510

4340

Acute renal failure

931

0.75

1.63

1.3

1.2

9.11

7.68

mmol/l

2.92

780

Exposure to other specified electric current

132

0.38

1.63

1.6

1.4

6.74

7.21

mmol/l

—

118

Trigger finger

102

801

1.28

1.62

1.2

7.47

7.50

mmol/l

0.03

697

Excessive attrition of teeth

540

4820

1.11

1.62

1.3

1.4

6.98

6.96

mmol/l

0.07

486

4305

Rheumatoid arthritis

147

1584

0.82

1.62

1.3

7.59

7.32

mmol/l

0.44

130

1398

Asthma, unspecified (mode), excluding more controls

436

2774

1.13

1.62

1.3

7.46

6.96

mmol/l

2.87

396

2408

Pollen allergy

122

1490

0.80

1.62

1.4

1.5

6.36

6.71

mmol/l

1.07

112

1363

Explicit bacterial Sepsis, including avohilmo

511

0.66

1.62

1.3

7.85

7.32

mmol/l

0.41

444

Malignant neoplasm of colon

606

0.69

1.61

1.2

7.94

7.70

mmol/l

0.19

504

Non-small cell lung cancer, including Hilmo

524

0.68

1.61

1.1

1.2

8.29

7.74

mmol/l

0.43

432

Ovarian dysfunction

101

795

1.28

1.60

1.7

1.6

7.22

6.59

mmol/l

1.28

734

Other abortion

2.36

1.60

1.6

1.4

5.95

7.04

mmol/l

—

Car occupant injured in other and unspecified transport accidents

160

1324

1.21

1.60

1.6

1.4

6.90

6.89

mmol/l

0.01

151

1200

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

851

5019

1.09

1.59

1.3

7.10

7.07

mmol/l

0.12

762

4441

Cervicobrachial syndrome

165

1371

1.21

1.58

1.3

7.37

7.22

mmol/l

0.31

145

1215

Dementia, including avohilmo

142

1182

0.82

1.58

1.2

8.01

7.94

mmol/l

0.08

118

954

Artificial joint operation, meniscal resection

612

3548

1.10

1.58

1.2

7.24

7.42

mmol/l

0.88

539

3081

Aplastic and other anaemias

194

2099

0.84

1.58

1.2

1.3

7.34

7.55

mmol/l

0.41

162

1790

COPD, early/later onset

167

1680

0.83

1.57

1.3

1.2

7.70

7.76

mmol/l

0.09

146

1424

Extrapyramidal and movement disorders

172

2048

0.84

1.53

1.3

1.2

7.45

7.48

mmol/l

0.05

150

1765

Achilles tendinitis

536

1.33

1.53

1.2

7.48

7.39

mmol/l

0.09

474

Disorders resulting from impaired renal tubular function

140

0.43

1.52

1.2

1.3

8.72

7.68

mmol/l

—

122

Cutis laxa senilis

2.63

1.52

1.3

1.2

5.43

7.29

mmol/l

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1156

0.78

1.52

1.3

1.4

6.72

7.02

mmol/l

0.62

1044

Dementia in other diseases classified elsewhere

140

0.43

1.52

1.3

1.2

8.23

7.55

mmol/l

—

115

Acute laryngitis and tracheitis

103

805

1.26

1.52

1.5

6.45

6.77

mmol/l

0.67

732

Codeine or tramadol medication

973

4895

1.08

1.51

1.3

1.4

7.31

6.98

mmol/l

2.89

873

4333

COPD, hospital admissions

166

1669

0.84

1.51

1.3

1.2

7.72

7.75

mmol/l

0.05

145

1417

Asthma, unspecified (mode)

441

2849

1.12

1.49

1.3

7.45

7.00

mmol/l

2.50

399

2470

Hodgkin lymphoma, hilmo

129

0.38

1.49

1.2

1.4

8.76

7.48

mmol/l

—

114

Impingement syndrome of shoulder

143

1180

1.21

1.49

1.1

1.2

7.77

7.64

mmol/l

0.15

120

1028

Medical observation and evaluation for suspected diseases and conditions

512

2356

1.11

1.48

1.3

7.11

6.94

mmol/l

0.66

447

2096

Fibroblastic disorders

133

1091

1.22

1.47

1.2

7.38

7.68

mmol/l

0.49

118

933

Seropositive rheumatoid arthritis, strict definition

778

0.74

1.47

1.4

1.3

7.06

7.39

mmol/l

0.42

684

Coxarthrosis, primary

325

2377

1.14

1.46

1.2

7.74

7.62

mmol/l

0.31

263

2037

Selective serotonin reuptake inhibitors

843

4043

1.08

1.46

1.3

1.4

7.27

7.02

mmol/l

1.48

743

3564

COPD

170

1639

0.84

1.46

1.3

1.2

7.71

7.60

mmol/l

0.18

149

1381

Ulcerative colitis (strict definition, all Crohn cases excluded)

901

0.76

1.45

1.3

1.4

6.61

6.99

mmol/l

0.85

817

Focal epilepsy, strict definition

1047

0.78

1.45

1.3

6.98

7.24

mmol/l

0.31

928

Exposure to other and unspecified animate mechanical forces

201

0.49

1.44

1.3

1.4

6.46

7.08

mmol/l

—

178

Retinal vascular occlusion

429

1.36

1.44

1.3

1.2

8.35

7.77

mmol/l

0.73

355

Other disorders of ear

687

4068

1.09

1.44

1.2

1.3

7.45

7.19

mmol/l

1.28

578

3601

Injuries to the head

830

5321

0.92

1.44

1.3

7.14

7.03

mmol/l

0.51

731

4739

Infections of breast associated with childbirth

345

1.40

1.44

1.7

1.6

6.15

6.62

mmol/l

1.22

316

Recurrent aphthous stomatitis , including avohilmo

104

834

1.25

1.43

1.4

6.86

7.09

mmol/l

0.37

753

Macular pucker

613

0.72

1.42

1.1

1.2

6.36

7.84

mmol/l

3.83

521

Use of donepezil

585

0.72

1.42

1.2

7.83

8.02

mmol/l

0.14

458

Plantar fascial fibromatosis

517

1.32

1.42

1.3

6.97

7.39

mmol/l

0.62

443

Liquid cancers, including Hilmo

149

1571

0.83

1.41

1.2

7.66

7.52

mmol/l

0.21

129

1340

Colorectal cancer, including Hilmo

1077

0.79

1.41

1.2

7.73

7.69

mmol/l

0.04

895

Focal epilepsy

1176

0.80

1.41

1.3

6.92

7.23

mmol/l

0.43

1045

Bus occupant injured in other and unspecified transport accidents

2.45

1.40

1.4

1.3

8.92

7.20

mmol/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

1008

0.78

1.40

1.3

6.69

7.24

mmol/l

1.12

892

Prolapse and hernia of ovary and fallopian tube

1.96

1.40

1.7

1.2

9.88

8.35

mmol/l

0.86

Carrier of infectious disease

111

1.73

1.39

1.4

7.16

7.26

mmol/l

0.04

Demyelinating diseases of the central nervous system

575

0.71

1.39

1.5

1.4

6.21

7.07

mmol/l

2.03

523

Primary_lymphoid and hematopoietic malignant neoplasms

1041

0.79

1.39

1.2

7.50

7.68

mmol/l

0.24

892

Unstable angina pectoris

177

1176

1.18

1.38

1.2

7.83

7.78

mmol/l

0.07

148

987

Gout

134

949

1.21

1.38

1.2

8.30

7.72

mmol/l

1.33

116

797

Depression or dysthymia

535

2651

1.10

1.37

1.3

7.10

7.08

mmol/l

0.04

475

2319

Immunodeficiency with predominantly antibody defects

123

0.40

1.37

1.4

5.76

7.29

mmol/l

—

104

Alcohol abuse, main dg, excluding more controls

994

0.78

1.37

1.3

7.61

7.07

mmol/l

0.68

893

Aortic aneurysm

887

0.77

1.37

1.2

7.99

7.79

mmol/l

0.22

733

Hernia of abdominal wall, postoperative

134

1102

1.21

1.37

1.4

1.3

7.10

7.37

mmol/l

0.49

114

930

Ocular pain

503

1.32

1.36

1.3

1.4

7.18

7.11

mmol/l

0.07

455

Colorectal cancer

996

0.79

1.36

1.2

7.88

7.68

mmol/l

0.23

823

Preparatory care for dialysis

163

0.49

1.36

1.1

1.3

8.04

7.27

mmol/l

—

142

Retinal vascular disorders

434

1.34

1.35

1.3

1.2

8.35

7.78

mmol/l

0.71

358

Lung transplant status

0.00

1.35

0.0

1.1

—

8.03

—

Lung transplantation

0.00

1.35

0.0

1.1

—

8.03

—

Crystalline deposits in vitreous body

0.00

1.35

0.0

1.2

—

7.53

—

Malignant neoplasm of floor of mouth, including Hilmo

0.00

1.34

0.0

1.3

—

7.45

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

0.00

1.34

0.0

1.4

—

7.52

—

Infections, IBD-co-morbidities

101

569

1.25

1.34

1.2

1.3

7.15

6.43

mmol/l

2.00

496

Other disorders of skin and subcutaneous tissue

431

4025

0.90

1.34

1.2

1.3

7.21

7.23

mmol/l

0.05

378

3531

Vasomotor rhinitis (mode)

341

1.38

1.34

1.3

7.06

7.40

mmol/l

0.31

300

Social phobias

730

0.75

1.33

1.4

1.5

7.33

6.58

mmol/l

1.09

670

Exfoliative dermatitis

0.00

1.33

0.0

1.2

—

7.73

—

Blepharochalasis

158

1333

1.19

1.33

1.3

1.2

7.59

7.75

mmol/l

0.25

130

1141

Ulcerative colitis

135

1616

0.83

1.32

1.3

7.09

7.07

mmol/l

0.03

119

1448

Other congenital malformations of intestine

0.00

1.32

0.0

1.4

—

7.45

—

Benign neoplasm: Conjunctiva

149

0.47

1.32

1.0

1.3

6.11

7.58

mmol/l

—

128

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

416

0.67

1.31

1.4

7.23

6.78

mmol/l

0.38

377

Abnormal findings on diagnostic imaging of lung

207

2264

0.86

1.30

1.2

7.40

7.63

mmol/l

0.52

180

1931

Symptoms and signs involving the nervous and musculoskeletal systems

416

3754

1.11

1.30

1.3

7.29

7.18

mmol/l

0.31

375

3291

Nasal polyp

118

971

1.22

1.30

1.2

7.59

7.39

mmol/l

0.31

101

849

Benign neoplasm of breast

659

0.74

1.30

1.3

6.39

7.29

mmol/l

1.81

587

Cholecystitis

569

1.29

1.2

7.78

7.51

mmol/l

0.28

495

Sequelae of injuries of upper limb

517

1.30

1.28

1.3

7.31

7.18

mmol/l

0.13

462

Traumatic subarachnoid haemorrhage

132

0.45

1.28

1.3

1.2

6.63

7.64

mmol/l

—

113

Migraine without aura

199

1718

1.16

1.28

1.4

1.5

6.58

6.64

mmol/l

0.11

186

1557

Other deformities of toe(s)

134

0.45

1.28

1.0

1.3

8.77

7.19

mmol/l

—

118

Other disorders of binocular movement

138

1.61

1.27

1.6

1.4

6.00

7.15

mmol/l

2.17

124

Azathioprine

938

0.79

1.27

1.4

7.03

mmol/l

0.00

838

Inflammatory bowel disease treatment related agents

866

5153

0.93

1.27

1.3

7.22

7.01

mmol/l

1.37

785

4562

Pulmonary heart disease, diseases of pulmonary circulation

125

1499

0.83

1.26

1.2

8.23

7.59

mmol/l

1.26

108

1289

ILD medications: azathioprine

937

0.79

1.26

1.4

7.03

7.01

mmol/l

0.03

836

Postmenopausal osteoporosis with pathological fracture

204

0.54

1.26

1.1

1.2

6.55

8.01

mmol/l

—

161

Injuries to the hip and thigh

237

2423

0.88

1.26

1.3

7.29

7.40

mmol/l

0.26

213

2074

Injuries to the thorax

238

2710

0.88

1.25

1.3

7.32

7.35

mmol/l

0.04

205

2354

Mental and behavioural disorders due to use of other stimulants, including caffeine

158

0.50

1.25

1.1

1.4

6.26

7.11

mmol/l

—

144

Seronegative juvenile rheumatoid arthritis

119

0.42

1.25

1.6

1.5

5.96

6.75

mmol/l

—

107

Myasthenia gravis

1.87

1.24

1.2

1.3

7.22

7.51

mmol/l

0.17

Mucosal proctocolitis

801

0.77

1.24

1.3

1.4

6.75

7.06

mmol/l

0.51

726

Papulosquamous disorders

268

2368

1.13

1.24

1.3

7.75

7.31

mmol/l

1.44

229

2083

Other viral diseases

189

2177

0.86

1.23

1.3

1.4

6.69

6.91

mmol/l

0.67

173

1963

Hypopituitarism

330

1.37

1.22

1.3

7.45

7.17

mmol/l

0.26

295

Other diseases of intestines

928

4832

1.07

1.20

1.3

1.4

7.12

6.98

mmol/l

0.74

825

4323

Polyp of the female genital tract

188

1233

0.86

1.20

1.3

1.4

7.43

6.94

mmol/l

1.58

162

1102

Viral conjunctivitis, including avohilmo

238

0.58

1.20

1.6

1.4

7.60

7.03

mmol/l

0.23

211

Ill-defined and unknown causes of mortality

336

0.65

1.20

1.2

7.61

7.71

mmol/l

0.04

281

Non-allergic asthma

400

1.33

1.20

1.6

1.3

7.90

7.16

mmol/l

0.87

356

Erysipelas, including avohilmo

429

3495

0.91

1.20

1.2

1.3

7.66

7.27

mmol/l

1.91

379

3044

Dislocation, sprain and strain of joints and ligaments of elbow

366

1.34

1.19

1.3

1.4

7.85

7.02

mmol/l

0.98

333

Postmenopausal bleeding

145

638

1.19

1.3

1.2

7.83

7.53

mmol/l

0.52

115

549

Injury of muscle and tendon at shoulder and upper arm level

215

1880

1.15

1.18

1.2

7.39

7.62

mmol/l

0.50

182

1619

Chronic kidney disease

107

1242

0.83

1.17

1.2

8.48

7.68

mmol/l

1.71

1034

Ulcerative colitis (strict definition, require KELA)

1071

0.81

1.17

1.3

1.4

6.73

7.01

mmol/l

0.55

970

Other antidepressants

849

4042

1.07

1.17

1.3

1.4

7.37

7.02

mmol/l

2.59

761

3563

Injury of cranial nerves

0.00

1.17

0.0

1.5

—

7.50

—

Emotionally unstable personality disorder

1114

0.81

1.17

1.4

1.5

6.85

6.67

mmol/l

0.30

1018

Malignant neoplasm of parotid gland

0.00

1.16

0.0

1.2

—

7.79

—

Exposure to excessive heat of man-made origin

0.00

1.16

0.0

1.2

—

7.43

—

Use of selegiline

128

0.47

1.16

1.2

7.50

mmol/l

—

107

Convulsions, not elsewhere classified

132

1541

0.84

1.16

1.3

1.4

7.32

7.03

mmol/l

0.46

123

1366

Right side

2.54

1.16

1.0

1.1

—

7.26

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.82

1.15

1.1

1.4

7.71

7.36

mmol/l

—

All dysplastic lesions of the vulva

207

1.46

1.15

1.3

7.28

7.36

mmol/l

0.06

181

COPD (mode)

124

1150

0.84

1.15

1.3

1.2

7.76

7.45

mmol/l

0.54

109

959

Gout, idiopatic and unspecified

117

977

1.20

1.14

1.2

8.35

7.71

mmol/l

1.37

101

809

Non-ischemic cardiomyopathy

105

1005

0.83

1.14

1.1

1.2

8.58

7.68

mmol/l

1.90

845

Spermatocele

266

1.40

1.14

1.1

1.2

7.16

7.73

mmol/l

0.74

231

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

281

2507

1.12

1.14

1.5

1.4

7.12

6.73

mmol/l

1.73

264

2274

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

527

1.27

1.13

1.4

1.5

6.36

6.69

mmol/l

0.64

485

Other noninfective gastroenteritis and colitis

123

1458

0.84

1.13

1.4

1.3

7.38

7.17

mmol/l

0.37

109

1295

Fracture at wrist and hand level

203

2308

0.88

1.12

1.3

6.96

7.11

mmol/l

0.32

188

2063

Streptococcal septicaemia

377

0.69

1.11

1.2

1.3

8.29

7.47

mmol/l

0.52

319

Soft tissue disorders related to use, overuse and pressure

173

1498

1.16

1.11

1.2

8.02

7.43

mmol/l

1.72

151

1307

Follicular cysts of skin and subcutaneous tissue

127

1073

1.19

1.10

1.2

1.3

7.64

7.18

mmol/l

0.80

107

958

Generalized skin eruption due to drugs and medicaments

182

0.55

1.10

1.1

1.4

6.75

7.52

mmol/l

—

159

Other/unspecified synovitis and tenosynovitis

620

1.25

1.09

1.5

1.3

7.38

7.39

mmol/l

0.02

544

Mental and behavioural disorders due to opioids

206

0.58

1.08

1.0

1.4

7.78

6.87

mmol/l

0.39

185

Nonsuppurative otitis media, including avohilmo

253

2454

0.89

1.08

1.5

6.80

6.67

mmol/l

0.39

236

2222

Conductive and sensorineural hearing loss

515

3145

1.09

1.08

1.2

7.60

7.37

mmol/l

0.88

430

2763

Later onset COPD

702

0.80

1.08

1.2

8.10

8.00

mmol/l

0.12

554

Concussion

410

2899

1.10

1.07

1.4

7.16

6.86

mmol/l

1.57

369

2563

Codeine

842

4262

1.07

1.06

1.4

7.30

6.91

mmol/l

3.46

759

3759

Malignant neoplasm of bladder, including Hilmo

380

0.70

1.06

1.1

1.2

8.07

7.87

mmol/l

0.12

306

Subacute thyroiditis

186

1.46

1.06

1.6

1.3

6.23

7.21

mmol/l

1.29

160

Cardiomyopathy

748

0.79

1.06

1.1

1.2

8.05

7.58

mmol/l

0.53

630

Coxarthrosis [arthrosis of hip](FG)

326

2022

1.11

1.06

1.2

7.80

7.58

mmol/l

0.66

268

1737

Suicide or other Intentional self-harm

152

1760

0.86

1.06

1.4

7.64

6.96

mmol/l

2.01

144

1581

Other diseases of liver

120

1014

1.19

1.05

1.3

7.91

7.28

mmol/l

1.17

105

893

Streptococcal septicaemia, including avohilmo

396

0.71

1.05

1.2

1.3

8.31

7.45

mmol/l

0.62

334

Non-rheumatic valve diseases

223

1798

0.88

1.05

1.1

1.2

7.58

7.49

mmol/l

0.19

195

1540

Hyperkinetic disorders, excluding more controls

116

1279

0.84

1.05

1.4

1.6

7.01

6.34

mmol/l

1.87

111

1175

Hypothermia

1.80

1.05

1.3

7.66

7.74

mmol/l

0.03

Molar incisor enamel hypoplasia

206

0.60

1.04

1.8

1.6

7.12

6.64

mmol/l

0.34

189

Benign neoplasm of brain and other parts of central nervous system

280

1.36

1.04

1.2

1.3

6.98

7.38

mmol/l

0.43

246

Postprocedural musculoskeletal disorders, not elsewhere classified

280

1.36

1.04

1.3

7.02

7.59

mmol/l

0.55

238

Unspecified mental disorder

316

2856

1.11

1.03

1.3

1.4

7.88

6.99

mmol/l

5.68

282

2556

Other extrapyramidal and movement disorders in other diseases

116

1369

0.85

1.03

1.3

7.43

7.40

mmol/l

0.04

1199

Open wound of head

297

3091

0.90

1.03

1.3

7.11

7.34

mmol/l

0.62

255

2692

Other renal tubulo-interstitial diseases

106

1.61

1.03

1.2

1.4

7.50

7.29

mmol/l

0.12

Glaucoma suspect

197

1732

1.14

1.03

1.2

7.80

7.60

mmol/l

0.44

184

1470

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1031

0.82

1.02

1.3

1.4

6.76

7.00

mmol/l

0.41

934

Major coronary heart disease event excluding revascularizations

326

1943

1.11

1.02

1.2

7.59

7.62

mmol/l

0.07

276

1656

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

165

1892

0.87

1.02

1.5

6.97

6.63

mmol/l

0.93

158

1726

Intestinal infectious diseases, including avohilmo, including avohilmo

946

4962

1.06

1.01

1.3

7.06

7.07

mmol/l

0.06

849

4391

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

357

3408

0.91

1.01

1.2

1.3

7.41

7.40

mmol/l

0.03

309

2959

Other inflammation of eyelid, including avohilmo

339

3726

0.91

1.01

1.3

1.4

6.98

6.92

mmol/l

0.14

319

3341

Misadventures to patients during surgical and medical care

772

1.21

1.00

1.2

1.3

7.14

7.32

mmol/l

0.26

688

Benign neoplasm of other and unspecified endocrine glands

645

1.23

1.00

1.3

7.68

7.34

mmol/l

0.48

570

Haemorrhoids and perianal venous thrombosis

216

1901

1.13

1.00

1.2

1.3

7.25

7.40

mmol/l

0.32

189

1653

LeFortI or BSSO operation

265

1.37

1.00

1.3

1.4

6.47

7.02

mmol/l

0.66

243

Other and unspecified injuries of lower leg

440

1.28

0.99

1.4

6.85

6.98

mmol/l

0.14

396

Chronic apical periodontitis

936

4947

1.06

0.99

1.4

1.3

7.24

6.99

mmol/l

1.59

828

4406

Female infertility

325

1763

1.11

0.99

1.5

6.81

6.59

mmol/l

0.91

294

1618

Alzheimer disease, excluding more controls

402

0.77

0.99

1.4

1.1

7.80

8.20

mmol/l

0.38

315

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

674

0.78

0.99

1.2

10.04

7.56

mmol/l

3.81

589

Acute generalized exanthematous pustulosis

200

0.60

0.98

1.1

1.4

6.92

7.43

mmol/l

0.43

173

Irritable bowel syndrome

222

1975

1.13

0.98

1.3

1.4

6.81

7.05

mmol/l

0.69

207

1772

Atrial fibrillation and flutter with reimbursement

144

780

1.16

0.98

1.1

8.12

7.24

mmol/l

2.79

128

659

Heartburn

665

1.22

0.98

1.3

1.4

7.03

7.10

mmol/l

0.08

590

Viral warts

617

0.78

0.98

1.4

6.69

6.95

mmol/l

0.32

564

Valvular heart disease excluding rheumatic fever

225

1804

0.89

0.98

1.1

1.2

7.55

7.48

mmol/l

0.14

197

1546

Injury of nerves and spinal cord at thorax level

0.00

0.98

0.0

1.2

—

7.96

—

Suggestive for eosinophilic asthma

432

1.28

0.98

1.2

1.3

7.57

7.31

mmol/l

0.25

377

Paralytic ileus and intestinal obstruction

103

1220

0.84

0.98

1.3

1.2

7.19

7.65

mmol/l

1.02

1047

Malignant neoplasm of base of tongue

0.00

0.98

0.0

1.1

—

8.12

—

Urolithiasis

189

1665

1.14

0.98

1.3

1.2

7.71

7.46

mmol/l

0.60

163

1444

Melanoma in situ of lower limb, including hip

0.00

0.98

0.0

1.1

—

7.27

—

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.98

0.0

1.1

—

8.45

—

Other and unspecified iron deficiency

177

2008

0.88

0.97

1.4

1.3

7.00

7.30

mmol/l

0.80

156

1750

Leiomyosarcoma

0.00

0.97

0.0

1.2

—

6.77

—

Hydronephrosis

549

1.24

0.97

1.4

1.3

7.66

7.40

mmol/l

0.28

481

Type 1 diabetes, wide definition, subgroup 2

0.00

0.96

0.0

1.6

—

6.86

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

101

850

1.19

0.96

1.6

1.5

6.51

6.65

mmol/l

0.26

777

Juvenile cataract

0.00

0.96

0.0

1.2

—

8.12

—

Retention of urine

132

1239

0.86

0.96

1.2

7.93

7.62

mmol/l

0.57

111

1045

Other and unspecified psoriasis

302

1.33

0.95

1.5

1.3

7.76

7.39

mmol/l

0.27

267

Other ill-defined and unspecified causes of mortality

306

0.68

0.95

1.2

7.49

7.73

mmol/l

0.10

259

Childhood asthma (age<16)

147

995

1.16

0.95

1.7

1.5

6.21

6.36

mmol/l

0.44

139

899

Opioids

884

4302

1.06

0.95

1.4

7.23

6.91

mmol/l

2.65

811

3795

Childhood asthma (age<16), excluding more controls

147

995

1.16

0.95

1.7

1.5

6.21

6.35

mmol/l

0.42

139

899

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

470

1.26

0.95

1.2

1.3

8.22

7.39

mmol/l

0.96

414

Increased muscle tone

1.91

0.94

1.1

1.4

6.56

7.31

mmol/l

—

Other chronic obstructive pulmonary disease

166

1549

0.88

0.94

1.3

1.2

7.70

7.66

mmol/l

0.05

145

1305

Viral conjunctivitis

118

0.51

0.94

1.0

1.4

7.89

7.46

mmol/l

—

103

Female genital prolapse

203

997

1.13

0.94

1.3

1.4

7.32

7.10

mmol/l

0.48

175

880

Benign neoplasm: Brain, unspecified

2.25

0.94

1.0

1.1

6.30

7.95

mmol/l

—

Disorders of thyroid, IBD co-morbidities

157

935

1.15

0.94

1.4

1.5

6.56

6.23

mmol/l

0.96

142

834

Pulmonary embolism

119

1387

0.86

0.93

1.2

8.31

7.57

mmol/l

1.47

103

1201

Other disorders of breast

943

0.83

0.93

1.4

7.57

6.97

mmol/l

1.18

840

Alcohol abuse, main dg

943

0.83

0.93

1.3

7.61

7.13

mmol/l

0.56

848

Hypoplasia of dental enamel , including avohilmo

189

0.61

0.93

1.9

1.6

7.07

6.71

mmol/l

0.22

174

Other obstructive and reflux uropathy

233

0.64

0.93

1.3

1.4

6.04

6.97

mmol/l

1.53

209

Myocardial infarction, unclassifiable

627

0.80

0.93

1.2

8.78

7.86

mmol/l

1.16

513

Postviral fatigue syndrome

1.84

0.93

1.2

1.5

7.08

7.35

mmol/l

—

Calculus of kidney and ureter

175

1541

1.14

0.93

1.3

7.75

7.44

mmol/l

0.75

154

1341

Atypical facial pain

243

1.36

0.93

1.3

7.03

7.50

mmol/l

0.40

212

Sensorineural hearing loss

469

2889

1.08

0.92

1.2

7.65

7.42

mmol/l

0.85

388

2527

Ménière disease

374

1.29

0.92

1.2

1.3

7.76

7.56

mmol/l

0.18

320

Osteitis due to dental implant

2.17

0.92

1.3

1.1

9.00

8.03

mmol/l

—

Maltreatment syndromes

348

1.30

0.92

1.4

7.15

6.98

mmol/l

0.16

318

Early lumbar disc prolapse, operated

726

1.20

0.91

1.4

6.86

6.93

mmol/l

0.07

661

Atopic dermatitis

555

4118

1.07

0.91

1.5

1.4

6.55

6.94

mmol/l

3.61

508

3721

Poisoning by medicine, drug-induced

1.76

0.90

1.3

1.4

8.37

7.67

mmol/l

0.36

Pulmonary heart disease

119

1382

0.86

0.90

1.2

8.31

7.57

mmol/l

1.47

103

1198

Specific personality disorders

175

1978

0.88

0.90

1.4

7.18

6.78

mmol/l

1.22

163

1791

Bilateral sagittal split ramus osteotomy operation

219

1.38

0.90

1.2

1.4

6.62

6.98

mmol/l

0.29

198

Calculus of lower urinary tract

185

1.41

0.89

1.2

1.3

7.33

7.42

mmol/l

0.05

158

Stroke, including SAH

283

2237

0.91

0.89

1.3

1.2

7.79

7.64

mmol/l

0.30

243

1900

Optic neuritis

254

0.67

0.89

1.4

6.41

7.12

mmol/l

0.62

225

Endovascular or surgical operations to intracerebral aneurysms

254

0.67

0.89

1.3

1.2

7.88

7.54

mmol/l

0.13

223

Chronic hepatitis NAS

1.80

0.88

1.5

1.3

8.02

7.34

mmol/l

—

Excessive, frequent and irregular menstruation

393

1928

1.09

0.88

1.4

1.5

6.84

6.64

mmol/l

0.92

355

1748

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

713

4235

1.06

0.88

1.3

7.20

7.22

mmol/l

0.09

626

3728

Striking against or struck by other objects

209

2329

0.89

0.87

1.3

6.90

7.03

mmol/l

0.31

181

2097

Other viral diseases, not elsewhere classified

101

1180

0.85

0.87

1.3

1.4

6.81

6.99

mmol/l

0.30

1064

Cauda equina syndrome

1.73

0.86

1.5

6.77

7.62

mmol/l

0.76

Retinal detachments and breaks

196

1749

1.12

0.86

1.2

7.40

7.64

mmol/l

0.51

154

1488

Infections of the skin and subcutaneous tissue

456

4167

1.08

0.85

1.4

1.3

7.23

7.08

mmol/l

0.49

416

3682

Defects in the complement system

1.96

0.85

1.0

1.5

6.52

7.13

mmol/l

—

Seropositive rheumatoid arthritis

110

1270

0.86

0.84

1.3

7.44

7.50

mmol/l

0.07

1103

Haemangioma, any site

415

1.26

0.84

1.5

1.3

7.69

7.29

mmol/l

0.37

369

Alcohol dependence

126

1448

0.87

0.84

1.2

7.75

7.35

mmol/l

0.67

113

1271

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

337

3656

0.92

0.84

1.2

1.3

7.22

7.25

mmol/l

0.07

310

3191

Phobic anxiety disorders

1155

0.85

0.84

1.3

1.5

7.32

6.63

mmol/l

1.74

1056

637

3962

0.94

0.84

1.4

1.3

7.32

7.01

mmol/l

1.88

566

3491

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

637

3962

0.94

0.84

1.4

1.3

7.32

7.01

mmol/l

1.88

566

3491

Other metabolic disorders

807

1.18

0.84

1.3

1.4

7.10

7.08

mmol/l

0.02

728

Other and/or unspecified nontoxic goitre

362

1.27

0.84

1.2

7.11

7.20

mmol/l

0.08

315

Gout, FINNGEN

134

1161

1.15

0.84

1.2

8.30

7.74

mmol/l

1.27

116

967

Other functional intestinal disorders

309

2567

1.09

0.84

1.4

1.3

7.24

7.22

mmol/l

0.04

275

2255

Acute suppurative otitis media

206

2136

0.90

0.83

1.5

6.98

6.64

mmol/l

0.80

193

1949

Polyarthrosis

106

818

1.17

0.83

1.2

8.35

7.58

mmol/l

1.25

702

Internal derangement of knee

221

2425

0.90

0.83

1.3

7.06

7.16

mmol/l

0.18

198

2134

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

227

2482

0.90

0.82

1.4

1.5

6.98

6.65

mmol/l

1.22

209

2263

Injury of muscle and tendon at hip and thigh level

534

1.22

0.82

1.2

1.3

7.01

7.33

mmol/l

0.53

475

Presbyopia

390

1.26

0.82

1.2

6.87

7.55

mmol/l

1.07

344

Contact with sharp glass

237

0.67

0.82

1.2

1.4

6.72

6.99

mmol/l

0.17

211

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

249

1.33

0.82

1.2

1.3

7.84

7.17

mmol/l

0.62

220

Abscess of Bartholin gland

189

0.63

0.81

1.3

1.5

6.59

6.87

mmol/l

0.13

171

Barrett oesophagus

206

1.36

0.81

1.2

6.99

7.58

mmol/l

0.50

174

Hereditary deficiency of other clotting factors

1.72

0.81

1.6

1.5

7.00

7.42

mmol/l

—

Symptoms and signs concerning food and fluid intake

552

1.21

0.81

1.4

1.3

7.54

7.18

mmol/l

0.37

493

Caries of enamel

801

4959

1.06

0.81

1.4

1.3

6.96

7.09

mmol/l

0.65

744

4377

Acute and transient psychotic disorders

654

1.20

0.81

1.3

8.64

7.06

mmol/l

3.25

587

Disorders of adult personality and behaviour

219

2424

0.90

0.81

1.4

7.07

6.78

mmol/l

0.95

204

2195

Triptan medication for migraine, min. 3 purchases

561

3929

1.07

0.80

1.4

6.75

6.80

mmol/l

0.17

521

3562

Otitis externa

132

1505

0.88

0.80

1.4

1.3

7.47

7.09

mmol/l

0.63

118

1342

Use of other anti-dementia drugs

668

0.83

0.80

1.2

8.00

8.06

mmol/l

0.05

517

Use of memantine

668

0.83

0.80

1.2

8.00

8.06

mmol/l

0.05

517

Other skin changes

116

1006

1.15

0.80

1.4

1.3

7.53

7.50

mmol/l

0.04

886

Other disorders of fluid, electrolyte and acid-base balance

124

1337

0.87

0.80

1.2

8.41

7.53

mmol/l

2.40

108

1146

Exposure to ignition of highly flammable material

0.00

0.79

0.0

1.1

—

8.03

—

Disorders of other and unspecified cranial nerves

0.00

0.79

0.0

1.2

—

7.29

—

Malignant neoplasm of floor of mouth

0.00

0.79

0.0

1.2

—

7.73

—

Polycystic ovarian syndrome, consortium definition

679

3670

1.06

0.79

1.4

7.13

6.77

mmol/l

3.13

631

3288

Hydrocephalus in other diseases

0.00

0.79

0.0

1.1

—

7.39

—

Embedded and impacted teeth

293

2176

1.09

0.79

1.5

6.33

6.48

mmol/l

0.67

266

1999

Pain, not elsewhere classified

215

1940

1.11

0.79

1.4

7.18

7.05

mmol/l

0.27

188

1718

Acute gastritis

303

1.29

0.79

1.3

7.15

7.47

mmol/l

0.21

265

Pediculosis, acariasis and other infestations, including avohilmo

141

1241

1.14

0.79

1.3

1.4

6.65

6.87

mmol/l

0.49

132

1123

Myocardial infarction, strict

229

1464

1.11

0.79

1.2

7.85

7.71

mmol/l

0.29

188

1245

Mental and behavioural disorders due to hallucinogens

0.00

0.79

0.0

1.4

—

7.35

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

137

1204

1.14

0.79

1.2

1.3

7.59

7.44

mmol/l

0.20

120

1057

Deviated nasal septum

206

1853

1.11

0.79

1.2

7.29

7.37

mmol/l

0.13

187

1615

Endometriosis

282

1794

0.91

0.79

1.4

1.5

6.94

6.65

mmol/l

1.28

255

1625

Presence of cardiac and vascular implants and grafts

217

1438

1.11

0.79

1.1

1.2

7.97

7.68

mmol/l

0.56

178

1203

Nutritional anaemias

260

2716

0.91

0.79

1.3

7.23

7.30

mmol/l

0.14

223

2357

Chronic conjunctivitis

151

0.59

0.78

1.2

1.4

7.30

7.38

mmol/l

—

130

Spasmodic torticollis

151

0.59

0.78

1.2

1.4

6.82

7.33

mmol/l

—

128

Stroke, excluding SAH

261

2066

0.91

0.78

1.3

1.2

7.83

7.66

mmol/l

0.33

222

1745

Fissure and fistula of anal and rectal regions

164

1459

1.13

0.78

1.3

7.39

7.29

mmol/l

0.17

148

1292

Congenital malformations of eye, ear, face and neck

393

1.25

0.78

1.4

1.5

7.37

6.83

mmol/l

0.63

356

Use of levodopa decarbox-comt-inhibitor

0.52

0.78

1.2

8.50

7.56

mmol/l

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

0.50

0.78

1.2

8.30

7.73

mmol/l

—

Benign neoplasm of ovary

901

0.84

0.77

1.2

1.3

6.73

7.44

mmol/l

1.83

785

Other complications of labour and delivery, not elsewhere classified

135

1051

1.14

0.77

1.7

1.5

6.39

6.44

mmol/l

0.10

124

965

Malignant neoplasm of oesophagus, including Hilmo

125

0.56

0.77

1.0

1.2

6.53

7.64

mmol/l

—

108

Malignant neoplasm of liver and intrahepatic bile ducts

100

0.50

0.77

1.0

1.2

7.12

7.45

mmol/l

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

857

0.84

0.77

1.2

8.65

7.64

mmol/l

1.69

711

Erysipelas

297

2786

0.92

0.77

1.2

7.76

7.39

mmol/l

1.17

257

2406

Open wound of abdomen, lower back and pelvis

162

0.61

0.77

1.3

1.4

5.96

7.26

mmol/l

—

144

malignant neoplasm of female genital organs, including Hilmo

806

0.84

0.77

1.2

1.3

8.21

7.53

mmol/l

0.86

685

Conductive hearing loss, unspecified

403

1.24

0.77

1.3

7.55

7.23

mmol/l

0.29

362

Complications of the puerperium, not elsewhere classified

377

1.25

0.76

1.4

1.5

6.84

6.73

mmol/l

0.12

351

Benign neoplasm: Ascending colon

576

1.20

0.76

1.2

8.08

7.65

mmol/l

0.51

497

Mandibular retrognathia AND surgery (BSSO)

166

1.39

0.76

1.2

1.4

6.48

7.22

mmol/l

0.78

151

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

281

2544

1.09

0.76

1.5

1.4

7.12

6.65

mmol/l

2.32

264

2294

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

107

1231

0.87

0.76

1.4

7.46

6.88

mmol/l

1.41

100

1120

Postprocedural endocrine and metabolic disorders, not elsewhere classified

742

1.18

0.76

1.3

1.4

7.03

7.07

mmol/l

0.05

668

Presbycusis

363

1.25

0.75

1.2

8.36

7.98

mmol/l

0.29

290

HSIL lesion of the vagina

1.66

0.75

1.4

1.5

7.74

6.95

mmol/l

0.37

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

194

1875

0.90

0.75

1.5

1.6

6.99

6.40

mmol/l

2.28

185

1731

Lesion of plantar nerve

244

1.32

0.75

1.3

1.2

7.03

7.63

mmol/l

0.54

213

Malignant neoplasm of prostate

110

750

0.87

0.75

1.2

1.1

7.17

7.61

mmol/l

0.77

634

Other disorders of eye and adnexa

102

882

1.16

0.75

1.3

1.4

7.08

7.02

mmol/l

0.08

799

Tongue abnormality

253

1.31

0.75

1.2

1.3

6.64

7.54

mmol/l

1.15

221

Venous thromboembolism

267

2805

0.92

0.75

1.3

7.59

7.43

mmol/l

0.37

237

2407

Mycoses, including avohilmo

684

5495

0.95

0.74

1.3

7.07

7.04

mmol/l

0.10

623

4866

Haemorrhage from respiratory passages

189

1505

1.11

0.74

1.2

1.3

7.63

7.44

mmol/l

0.36

161

1296

Juvenile rheumatoid arthirtis

132

0.60

0.74

1.3

1.4

5.61

7.03

mmol/l

—

118

Other and unspecified rosacea

496

1.21

0.74

1.3

7.42

7.34

mmol/l

0.06

444

Oral corticosteroids

808

4980

0.95

0.73

1.3

7.28

7.03

mmol/l

1.67

733

4401

Collagenous colitis

447

0.78

0.73

1.2

1.3

7.26

7.31

mmol/l

0.05

396

ILD medications

890

5032

0.95

0.73

1.4

1.3

7.26

6.99

mmol/l

1.96

806

4453

Disorders of other endocrine glands

332

3022

1.08

0.73

1.4

7.39

7.02

mmol/l

1.22

303

2678

Colorectal adenocarcinoma

830

0.84

0.73

1.2

7.97

7.72

mmol/l

0.27

681

Coxibs

203

959

1.11

0.73

1.3

1.4

7.30

6.88

mmol/l

1.06

177

825

Acquired absence of limb

1.81

0.73

1.0

1.2

8.19

7.35

mmol/l

—

Hydrocele

379

1.24

0.72

1.1

6.84

7.66

mmol/l

1.13

328

Nonsuppurative otitis media

178

1715

0.90

0.72

1.6

1.5

6.80

6.58

mmol/l

0.59

164

1565

Disorders of sclera, cornea, iris and ciliary body

351

3780

0.93

0.72

1.4

1.3

7.05

7.16

mmol/l

0.36

312

3344

Pleural effusion

567

0.81

0.71

1.3

1.2

8.19

7.68

mmol/l

0.54

468

Contact with machinery

507

1.21

0.71

1.1

1.2

7.55

7.46

mmol/l

0.10

443

Chronic periodontitis, complicated

363

3287

1.08

0.71

1.3

1.2

7.94

7.38

mmol/l

1.97

303

2872

Myopia

978

0.86

0.71

1.4

1.5

6.96

6.87

mmol/l

0.13

887

Hypermetropia

362

1.25

0.71

1.5

1.4

6.64

7.12

mmol/l

0.70

323

Other and unspecified nonorganic psychotic disorders

146

1300

1.12

0.71

1.3

1.4

8.18

6.88

mmol/l

4.86

138

1177

Lichen planus, including avohilmo

111

971

1.14

0.71

1.2

7.67

7.42

mmol/l

0.32

861

Gout, strict definition

701

1.17

0.70

1.1

1.2

8.39

7.80

mmol/l

0.95

580

Disorders of calcium metabolism

238

1.31

0.70

1.2

1.3

7.64

7.47

mmol/l

0.15

212

Osteoporosis with pathological fracture (FG)

229

0.70

1.2

6.86

8.04

mmol/l

—

187

Other maltreatment syndromes

160

1.38

0.70

1.5

1.3

7.05

7.48

mmol/l

0.29

143

Other symptoms and signs involving cognitive functions and awareness

269

2191

1.09

0.69

1.2

1.3

7.20

7.55

mmol/l

1.32

242

1886

Polymyalgia rheumatica

463

1.21

0.69

1.2

7.91

7.69

mmol/l

0.21

386

Diagnoses used for exclusion with ILD

106

1210

0.87

0.69

1.2

7.56

7.53

mmol/l

0.03

1053

Pacemaker

125

1312

0.88

0.69

1.1

1.2

7.71

7.86

mmol/l

0.19

104

1081

Kela-code for severe mental illness

267

2457

1.09

0.69

1.3

8.04

7.04

mmol/l

5.91

246

2196

Benign neoplasms

858

4450

1.05

0.69

1.3

1.4

7.04

6.98

mmol/l

0.27

761

3993

Complications following infusion, transfusion and therapeutic injection

1.65

0.69

1.4

1.3

9.58

7.60

mmol/l

—

Androgenic alopecia

1.68

0.68

1.3

1.5

6.80

6.90

mmol/l

—

Scabies, including avohilmo

121

1068

1.13

0.68

1.3

1.4

6.60

6.76

mmol/l

0.28

113

969

Other anxiety disorders

395

3594

0.93

0.68

1.4

6.77

6.82

mmol/l

0.13

366

3262

Cervicalgia

137

1219

1.13

0.68

1.3

7.15

7.31

mmol/l

0.30

128

1066

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

789

1.16

0.67

1.7

1.5

6.33

6.55

mmol/l

0.56

726

Depression medications

292

1352

1.09

0.67

1.4

1.5

6.75

6.16

mmol/l

2.91

265

1214

Other diseases caused by chlamydiae, including avohilmo

0.55

0.67

1.8

1.5

5.64

7.38

mmol/l

—

Xanthelasma of eyelid

1.64

0.67

1.0

1.2

8.54

7.30

mmol/l

—

Certain infectious and parasitic diseases

794

4173

0.95

0.67

1.3

1.4

7.10

6.98

mmol/l

0.60

723

3715

Malignant melanoma

714

0.84

0.67

1.2

7.26

7.56

mmol/l

0.35

601

Thyroiditis

402

1.22

0.67

1.4

6.37

7.16

mmol/l

1.49

359

Poisoning by drugs, medicaments and biological substances

162

1797

0.90

0.66

1.4

7.16

6.84

mmol/l

0.81

151

1621

Burn and corrosion of head and neck

0.52

0.66

1.4

7.52

7.74

mmol/l

—

Thyrotoxicosis with diffuse goitre

103

902

1.14

0.66

1.4

6.78

6.99

mmol/l

0.38

804

Fall on and from ladder

312

1.25

0.66

1.3

1.2

7.61

7.37

mmol/l

0.18

273

Retinoschisis and retinal cysts

1.52

0.66

1.1

8.49

7.23

mmol/l

—

Other bursopathies

641

1.17

0.66

1.3

1.2

6.39

7.61

mmol/l

4.85

555

Malignant melanoma of skin

517

0.81

0.66

1.2

7.38

7.64

mmol/l

0.21

440

Uterine polyps

173

1120

0.90

0.66

1.3

1.4

7.44

7.01

mmol/l

1.18

150

993

Disorder of lipoprotein metabolism, unspecified

457

1.21

0.66

1.3

1.2

8.25

7.72

mmol/l

0.58

395

Ulcerative enterocolitis

155

0.64

0.66

1.5

1.4

7.52

7.21

mmol/l

—

135

Genitourinary diseases

466

2193

1.07

0.66

1.3

7.13

6.98

mmol/l

0.51

413

1941

Colectomy operation

691

0.84

0.66

1.2

1.3

7.89

7.56

mmol/l

0.37

595

Oter anti-inflammatory and antirheumatic agents, non-steroids

112

539

1.14

0.66

1.2

7.49

7.40

mmol/l

0.08

445

Symptoms and signs involving speech and voice

175

1932

0.90

0.65

1.3

7.04

7.37

mmol/l

1.01

161

1691

Benign leiomyoma with endometriosis

755

0.85

0.65

1.2

1.3

7.34

7.52

mmol/l

0.21

651

Other systemic involvement of connective tissue (FG)

161

1425

1.11

0.64

1.2

1.3

7.16

7.31

mmol/l

0.27

146

1251

Impacted teeth

218

1712

1.09

0.64

1.4

1.6

6.26

6.48

mmol/l

0.96

200

1577

Arteriovenous malformation of peripheral vessels

1.74

0.64

1.8

1.4

6.84

7.80

mmol/l

—

Myocardial infarction

246

1579

1.09

0.64

1.2

7.86

7.66

mmol/l

0.44

201

1347

Postpartum hemorraghe, parous women as controls

343

2675

1.07

0.64

1.6

1.5

6.30

6.50

mmol/l

1.27

324

2440

Chalazion

653

1.17

0.64

1.4

6.32

7.13

mmol/l

2.62

585

Embolic stroke

130

0.61

0.63

1.7

1.2

7.70

7.64

mmol/l

—

108

Other diseases of the digestive system

131

1464

0.89

0.63

1.2

7.84

7.53

mmol/l

0.54

109

1257

Other predominantly sexually transmitted diseases, not elsewhere classified

132

1474

0.89

0.62

1.5

7.11

6.72

mmol/l

0.90

125

1342

Hernia

675

4266

1.05

0.62

1.3

7.18

7.21

mmol/l

0.13

611

3743

Endometriosis diagnosis and infertility diagnosis occurring together

100

879

1.14

0.62

1.4

1.5

6.73

6.80

mmol/l

0.13

795

Congenital hypothyroidism without goiter

1.68

0.62

1.6

5.80

7.29

mmol/l

—

Haemangioma and lymphangioma, any site

452

1.20

0.61

1.5

1.3

7.60

7.27

mmol/l

0.31

403

Benign neoplasm of mouth and pharynx

498

1.19

0.61

1.3

7.58

7.34

mmol/l

0.23

444

Other noninflammatory disorders of uterus, except cervix

121

717

1.13

0.61

1.2

1.3

7.52

7.39

mmol/l

0.19

104

622

Polyarthropathies

450

3065

0.94

0.61

1.3

7.61

7.05

mmol/l

3.40

400

2710

Corneal ulcer

101

1143

0.88

0.60

1.4

1.3

7.10

7.13

mmol/l

0.03

1031

Malignant neoplasm of hypopharynx, including Hilmo

0.00

0.60

0.0

1.2

—

7.76

—

Viral pneumonia (unknown virus, not influenza)

334

0.78

0.60

1.3

6.16

7.13

mmol/l

1.71

298

Other and unspecified effects of external causes

224

2062

1.09

0.60

1.4

7.23

6.88

mmol/l

1.02

203

1854

Complications following myocardial infarction

0.00

0.60

0.0

1.2

—

7.23

—

Schizophrenia or delusion

228

2101

1.09

0.60

1.3

8.18

7.01

mmol/l

6.45

211

1881

malignant neoplasm of male genital organs

117

792

0.89

0.60

1.2

1.1

7.25

7.60

mmol/l

0.56

673

Hypothyroidism due to medicaments and other exogenous substances

1.55

0.59

1.1

1.3

6.61

7.13

mmol/l

—

Hypo-osmolality and hyponatraemia

699

0.85

0.59

1.2

8.66

7.72

mmol/l

1.34

598

Chronic pancreatitis

542

0.83

0.59

1.2

9.25

7.47

mmol/l

2.08

476

Alcohol withdrawal state with delirium

288

0.76

0.59

1.1

1.2

8.67

7.47

mmol/l

0.90

250

Peripheral artery operations in Hilmo

432

0.81

0.59

1.1

1.2

8.98

7.72

mmol/l

1.25

362

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.58

0.0

1.1

—

8.56

—

Benign neoplasm: Skin of eyelid, including canthus

696

1.15

0.58

1.3

1.2

7.13

7.50

mmol/l

0.57

609

Ischaemic Stroke, excluding all haemorrhages

240

1910

0.92

0.58

1.3

1.2

7.76

7.70

mmol/l

0.09

203

1606

Anaemias

220

1296

1.09

0.58

1.4

1.5

6.69

6.15

mmol/l

2.68

198

1160

Acute appendicitis, with complications

1097

0.88

0.58

1.1

1.3

7.83

7.28

mmol/l

0.85

974

Anxiety disorders

758

4972

1.05

0.58

1.4

1.3

7.03

7.00

mmol/l

0.08

688

4426

Crohn disease

799

0.86

0.58

1.4

7.23

6.99

mmol/l

0.27

724

Cerebral palsy and other paralytic syndromes

529

1.17

0.58

1.3

7.31

7.14

mmol/l

0.18

472

Other disorders of cornea

446

1.19

0.58

1.4

1.3

7.51

7.41

mmol/l

0.07

393

Post-traumatic stress disorder

873

0.87

0.58

1.5

7.36

6.58

mmol/l

1.54

806

Acute alcohol intoxication ICD-9

116

0.60

0.57

1.7

1.2

7.97

7.55

mmol/l

—

104

Other puerperal infections

801

1.14

0.57

1.7

1.6

6.52

6.56

mmol/l

0.04

739

Diseases of salivary glands

229

2116

1.08

0.57

1.4

1.3

7.15

7.17

mmol/l

0.03

211

1880

Undetermined asthma, excluding more controls

763

1.14

0.57

1.3

7.22

7.10

mmol/l

0.16

666

Pedal cyclist injured in other and unspecified transport accidents

636

0.85

0.56

1.4

6.88

7.05

mmol/l

0.17

573

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.57

0.56

1.4

1.3

7.28

7.21

mmol/l

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

0.57

0.56

1.4

1.3

7.28

7.21

mmol/l

—

Cardiac murmurs and other cardiac sounds

543

1.17

0.56

1.4

1.5

6.89

6.86

mmol/l

0.04

491

Other arterial embolism and thrombosis

0.58

0.56

1.0

1.2

5.87

7.55

mmol/l

—

Drug-induced neutropenia

308

0.78

0.56

1.4

1.3

8.97

7.40

mmol/l

1.20

268

Adenocarcinoma of pancreas

0.57

0.56

1.8

1.2

7.77

7.44

mmol/l

—

Melanocytic naevi, other sites/unspecified

485

1.18

0.56

1.4

6.89

7.14

mmol/l

0.33

436

Other complications of surgical and medical care, not elsewhere classified

522

1.17

0.56

1.4

1.3

7.00

7.20

mmol/l

0.30

467

Postpartum haemorrhage due to retained placenta

148

1628

0.91

0.56

1.5

1.6

6.45

6.48

mmol/l

0.07

138

1484

Bronchitis, not specified as acute or chronic

384

1.20

0.55

1.3

7.09

7.18

mmol/l

0.08

333

Heart failure and coronary heart disease

154

1186

0.91

0.55

1.2

8.20

7.75

mmol/l

0.89

138

990

Personality disorders, excluding more controls

211

2279

0.92

0.55

1.4

7.17

6.71

mmol/l

1.85

196

2054

Myocardial infarction, with ST-elevation

625

1.15

0.55

1.2

7.91

7.85

mmol/l

0.05

524

Superficial injury of head

129

1427

0.90

0.55

1.3

7.06

7.21

mmol/l

0.30

111

1258

Hypertrophic disorders of skin

348

1.21

0.55

1.2

1.4

6.72

7.00

mmol/l

0.23

313

Phlebitis and thrombophlebitis (not including DVT)

139

1259

1.11

0.54

1.4

1.3

6.89

7.40

mmol/l

1.48

123

1116

Other and unspecified glaucoma

228

0.74

0.54

1.1

1.2

8.72

7.81

mmol/l

0.53

192

Syncope and collapse

265

2373

0.93

0.54

1.3

7.24

7.20

mmol/l

0.07

236

2066

Retinal breaks without detachment

815

0.87

0.54

1.1

1.2

6.60

7.56

mmol/l

2.80

714

Assault by other specified means

1.49

0.54

1.1

1.4

7.82

7.79

mmol/l

—

Hidradenitis suppurativa

249

1.25

0.54

1.2

1.4

7.22

7.02

mmol/l

0.17

226

Benign neoplasm of eye and adnexa

487

1.17

0.54

1.2

1.3

6.70

7.39

mmol/l

1.21

425

Ventricular septal defect, a heart condition

1.47

0.54

1.3

1.5

6.53

7.16

mmol/l

0.53

Used for control exclusion in common control thyroid runs

898

4353

1.04

0.53

1.4

1.3

7.29

6.95

mmol/l

2.57

798

3872

Fracture of lower leg, including ankle

344

3586

0.94

0.53

1.3

7.43

7.17

mmol/l

0.79

307

3148

Early onset COPD

1089

0.89

0.53

1.4

1.2

7.45

7.57

mmol/l

0.15

952

Spinal instabilities

134

1.35

0.53

1.2

1.3

6.58

7.30

mmol/l

0.56

114

Schizophrenia, schizotypal and delusional disorders

227

2106

1.08

0.53

1.3

8.20

7.01

mmol/l

6.66

210

1884

GI-bleeding

132

1456

0.91

0.53

1.2

7.78

7.53

mmol/l

0.41

109

1252

Exposure to other and unspecified inanimate mechanical forces

415

0.82

0.53

1.6

1.4

7.21

7.00

mmol/l

0.12

378

Galactorrhea

1.53

0.53

1.6

7.90

6.76

mmol/l

—

Heart failure and antihypertensive medication

103

595

1.12

0.53

1.2

8.10

6.81

mmol/l

3.63

497

Certolizumab pegol

143

1.34

0.53

1.9

1.5

6.25

6.78

mmol/l

0.64

125

Stomatitis and related lesions

137

1243

1.10

0.53

1.3

1.4

6.96

7.10

mmol/l

0.23

128

1118

Migraine without aura, drug-induced

1.44

0.52

1.3

1.5

8.01

7.13

mmol/l

—

Other gastritis (incl. Duodenitis)

121

1091

1.11

0.52

1.3

7.48

7.54

mmol/l

0.07

110

945

Injury of nerves at forearm level

1.44

0.52

1.3

1.4

7.07

7.41

mmol/l

—

Conjunctivitis (acute, non atopic)

192

2071

0.92

0.52

1.4

7.24

7.02

mmol/l

0.43

177

1860

Trochanteric bursitis

713

1.14

0.52

1.2

8.17

7.63

mmol/l

0.81

612

Embedded teeth, including avohilmo

770

1.13

0.52

1.5

1.6

6.58

6.60

mmol/l

0.03

704

Behavioural disorders, excluding more controls

132

0.68

0.52

1.2

1.5

8.22

6.61

mmol/l

—

123

Neurotic, stress-related and somatoform disorders

750

4956

1.04

0.52

1.4

1.3

7.03

7.00

mmol/l

0.10

680

4416

Zoster [herpes zoster], including avohilmo

329

2986

1.06

0.51

1.3

7.35

7.32

mmol/l

0.07

295

2593

Other congenital malformations of the digestive system

179

0.72

0.51

1.6

1.4

5.89

7.21

mmol/l

2.17

159

Redundant prepuce, phimosis and paraphimosis

851

1.12

0.51

1.1

8.29

7.53

mmol/l

1.05

738

Weight loss

471

1.17

0.51

1.4

1.3

7.46

7.16

mmol/l

0.24

414

Other noninflammatory disorders of vagina

499

1.16

0.51

1.5

6.95

6.94

mmol/l

0.01

450

Open wound of ankle and foot

554

0.85

0.51

1.4

7.05

6.98

mmol/l

0.05

500

Atopic dermatitis, strict definition

275

2516

1.07

0.51

1.5

1.4

6.73

6.69

mmol/l

0.12

257

2285

Herpesviral [herpes simplex] infections, including avohilmo

188

2036

0.92

0.51

1.4

6.92

6.89

mmol/l

0.06

167

1835

Poisoning by medicine

147

1609

0.91

0.51

1.3

1.4

7.21

6.85

mmol/l

0.90

136

1462

Degeneration of macula and posterior pole

190

1587

0.92

0.50

1.2

7.64

7.82

mmol/l

0.29

166

1325

Sequelae of external causes of morbidity and mortality

132

1451

0.91

0.50

1.4

1.3

7.52

7.40

mmol/l

0.19

122

1273

Benign neoplasm: Rectum

772

1.13

0.50

1.1

1.2

7.62

7.68

mmol/l

0.05

671

Other benign neoplasms of skin

224

2083

1.08

0.50

1.3

7.21

7.37

mmol/l

0.36

187

1826

Impacted cerumen

488

0.84

0.50

1.2

1.3

6.91

7.47

mmol/l

0.62

421

Sudden idiopathic hearing loss

454

1.17

0.50

1.3

7.49

7.42

mmol/l

0.06

400

Undetermined asthma

772

1.13

0.50

1.3

7.22

7.08

mmol/l

0.19

676

Other peripheral vertigo

380

1.19

0.49

1.4

1.3

7.27

7.47

mmol/l

0.18

331

Symptoms and signs involving the urinary system

499

3585

1.05

0.49

1.3

7.52

7.25

mmol/l

1.11

444

3126

Personality disorders

211

2269

0.93

0.49

1.4

7.17

6.80

mmol/l

1.32

196

2052

Injury of muscle and tendon at lower leg level

807

0.88

0.49

1.1

1.2

7.65

7.40

mmol/l

0.29

718

Benign neoplasm: Rectum, anus and anal canal

878

1.12

0.49

1.1

1.2

7.49

7.71

mmol/l

0.23

758

Peritonsillar abscess

173

1595

1.09

0.49

1.3

1.4

6.61

6.87

mmol/l

0.85

155

1443

Parkinson's disease, including avohilmo

551

0.85

0.49

1.3

1.2

8.08

7.76

mmol/l

0.38

459

Other disorders of skin and subcutaneous tissue, not elsewhere classified

711

0.87

0.48

1.2

1.3

7.20

7.38

mmol/l

0.14

620

Use of pramipexole

1039

0.89

0.48

1.3

1.2

7.29

7.58

mmol/l

0.46

901

Lichen sclerosus et atrophicus

586

1.15

0.48

1.2

7.13

7.49

mmol/l

0.44

512

Other protozoal intestinal diseases, including avohilmo

119

1.35

0.48

1.3

1.4

6.50

7.22

mmol/l

0.89

103

Hypertensive heart and/or renal disease

101

661

1.12

0.48

1.1

1.2

8.03

7.46

mmol/l

1.26

549

Malignant melanoma of skin, including Hilmo

657

0.87

0.48

1.2

7.79

7.58

mmol/l

0.15

562

Benign mammary dysplasia

710

0.87

0.48

1.3

6.62

7.41

mmol/l

2.25

611

Hypertensive Heart Disease

608

1.12

0.48

1.1

1.2

7.85

7.56

mmol/l

0.45

500

Enterocolitis due to Clostridium difficile

431

0.83

0.47

1.3

7.23

7.48

mmol/l

0.20

372

Motor disorders

1.48

0.47

1.3

1.7

8.41

7.00

mmol/l

—

Other congenital malformations of peripheral vascular system

1.48

0.47

1.8

1.5

8.32

7.15

mmol/l

—

179

1488

1.08

0.47

1.2

7.39

7.86

mmol/l

1.18

145

1242

Hyperkinetic disorders

116

1245

0.91

0.47

1.4

1.6

7.01

6.45

mmol/l

1.42

111

1147

Finngen Rheumatological endpoints

815

4457

1.04

0.46

1.3

1.4

7.20

6.95

mmol/l

1.60

728

3975

Specific developmental disorder of motor function

1.45

0.46

1.3

1.7

8.41

6.93

mmol/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

995

0.90

0.46

1.2

1.4

7.15

7.03

mmol/l

0.15

896

Exophthalmic conditions

1.44

0.46

1.4

1.3

6.71

7.33

mmol/l

—

Other immunodeficiencies

1.44

0.46

1.1

1.4

6.13

7.20

mmol/l

—

Malignant neoplasm of prostate, including Hilmo

118

767

0.91

0.46

1.2

1.1

7.21

7.60

mmol/l

0.69

100

649

Gastroduodenal ulcer

1041

0.90

0.45

1.2

8.15

7.76

mmol/l

0.46

878

Gender identity disorders

0.58

0.45

1.2

1.7

6.80

6.82

mmol/l

—

Melanocytic naevi of trunk

770

0.88

0.45

1.4

6.73

7.05

mmol/l

0.42

693

Duodenal ulcer

385

0.83

0.45

1.2

8.49

7.60

mmol/l

0.57

323

Complications of medical and surgical care

488

4583

0.96

0.45

1.3

7.31

7.13

mmol/l

0.68

440

4030

Kyphosis

1.41

0.45

1.3

1.2

8.00

7.52

mmol/l

—

Pain associated with micturition

609

1.13

0.45

1.2

1.3

6.74

7.16

mmol/l

0.69

540

Implicit viral Sepsis

1085

0.90

0.45

1.3

7.55

7.42

mmol/l

0.17

944

Viral Sepsis

1085

0.90

0.45

1.3

7.55

7.42

mmol/l

0.17

944

Dystonia

264

0.79

0.44

1.2

1.3

6.99

7.45

mmol/l

0.49

227

Injuries to the abdomen, lower back, lumbar spine and pelvis

240

2520

0.94

0.44

1.4

1.3

7.17

7.18

mmol/l

0.02

222

2201

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.46

0.44

1.3

1.4

7.17

7.57

mmol/l

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

108

980

1.10

0.44

1.3

1.2

7.63

7.75

mmol/l

0.19

101

838

Isolated proteinuria with specified morphological lesion

1.38

0.44

1.4

1.3

7.36

7.34

mmol/l

—

Melanoma in situ of trunk

1.38

0.44

1.4

1.2

8.23

7.63

mmol/l

—

Skin changes due to chronic exposure to nonionizing radiation

163

1364

1.08

0.44

1.2

7.48

7.88

mmol/l

0.83

131

1132

Schizophrenia or delusion, excluding more controls

228

2109

1.07

0.44

1.3

1.4

8.18

6.95

mmol/l

7.03

211

1878

Primary coxarthrosis, bilateral

133

1220

1.09

0.44

1.2

7.63

7.77

mmol/l

0.24

113

1030

Other inflammation of eyelid

778

0.89

0.43

1.2

1.3

7.40

7.33

mmol/l

0.07

689

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

907

0.90

0.43

1.2

1.4

7.08

7.04

mmol/l

0.05

817

Herpesviral [herpes simplex] infections

696

1.12

0.43

1.3

1.4

7.18

7.19

mmol/l

0.01

630

All dysplastic lesions of the cervix uteri

244

2554

0.94

0.43

1.5

6.91

6.64

mmol/l

0.77

232

2336

Iron deficiency anaemia

234

2444

0.94

0.43

1.3

7.19

7.29

mmol/l

0.21

203

2123

Other specified/unspecified arthritis

176

1635

1.08

0.43

1.3

7.46

7.25

mmol/l

0.36

156

1440

Allergic rhinitis

237

2490

0.94

0.43

1.4

6.63

6.84

mmol/l

0.59

217

2242

Panic disorder

122

1332

0.91

0.43

1.4

1.5

6.85

6.64

mmol/l

0.41

116

1219

Appendicitis, broad definition

587

5059

1.04

0.43

1.4

1.3

7.20

7.03

mmol/l

0.75

530

4500

DVT of lower extremities and pulmonary embolism

196

2090

0.93

0.43

1.3

1.2

7.87

7.48

mmol/l

0.95

171

1791

Disturbance of activity and attention

114

1218

0.91

0.43

1.4

1.6

6.94

6.46

mmol/l

1.15

109

1124

Diffuse brain injury

151

0.73

0.43

1.2

1.3

7.96

6.95

mmol/l

0.39

137

Postzoster neuralgia

1.43

0.42

1.3

1.2

8.19

8.08

mmol/l

—

malignant neoplasm of male genital organs, including Hilmo

124

814

0.91

0.42

1.2

1.1

7.30

7.63

mmol/l

0.54

105

691

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

0.66

0.42

1.3

1.5

6.95

mmol/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

369

3384

1.05

0.42

1.3

7.22

7.21

mmol/l

0.02

335

2981

Intracranial injury

385

3763

0.95

0.42

1.4

1.3

7.25

7.13

mmol/l

0.39

345

3311

Common variable immunodeficiency

1.57

0.42

1.4

1.2

4.66

8.22

mmol/l

—

Seminoma of testis

1.57

0.42

1.0

1.1

9.18

7.82

mmol/l

—

Other localized connective tissue disorders

0.64

0.42

1.2

1.4

6.96

7.24

mmol/l

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

380

3908

0.95

0.42

1.2

1.3

7.34

7.21

mmol/l

0.35

344

3421

Diseases of appendix

590

5070

1.04

0.42

1.4

1.3

7.21

7.04

mmol/l

0.80

533

4509

Adjustment and management of implanted device

617

0.87

0.42

1.1

1.2

8.11

7.80

mmol/l

0.27

514

Other viral diseases, including avohilmo

297

3105

0.95

0.42

1.4

6.71

6.84

mmol/l

0.44

274

2796

Early lumbar disc prolapse operation

793

1.11

0.42

1.4

6.84

6.95

mmol/l

0.11

735

Reactive arthropathies

434

1.15

0.42

1.2

1.3

6.46

7.30

mmol/l

1.61

384

Dermatitis

461

4314

1.05

0.42

1.3

6.96

7.14

mmol/l

0.75

398

3810

Aggressive periodontitis

1.36

0.41

1.5

1.3

8.28

7.30

mmol/l

0.57

LSIL lesion of the cervix uteri, vagina or vulva

111

1214

0.91

0.41

1.4

1.5

7.00

6.77

mmol/l

0.41

104

1103

Other disorders of bone

140

1292

1.08

0.41

1.3

7.15

7.09

mmol/l

0.10

124

1155

Other diseases of anus and rectum

175

1623

1.07

0.41

1.2

1.3

7.32

7.45

mmol/l

0.27

148

1414

Synovial hypertrophy, not elsewhere classified

1.36

0.41

1.1

1.5

5.63

7.32

mmol/l

—

Other injuries of upper limb, level unspecified

1.36

0.41

1.3

1.4

6.79

7.64

mmol/l

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.41

0.0

1.2

—

7.41

—

Dizziness and giddiness

540

4032

1.04

0.41

1.3

7.13

7.20

mmol/l

0.22

472

3567

Other disorders of patella

130

1197

1.09

0.40

1.3

7.09

7.11

mmol/l

0.02

119

1072

Benign neoplasm: Stomach

370

1.16

0.40

1.3

1.2

7.33

7.61

mmol/l

0.28

318

Other infectious diseases, including avohilmo

417

1.15

0.40

1.2

1.3

7.46

7.28

mmol/l

0.14

365

Other disorders of urethra and urinary system

569

3806

1.04

0.40

1.3

1.4

7.16

7.00

mmol/l

0.74

500

3365

Abnormal findings on diagnostic imaging of central nervous system

278

1.19

0.40

1.3

1.4

7.69

7.25

mmol/l

0.19

244

Superficial injury of lower leg

192

1797

1.07

0.40

1.4

6.96

7.08

mmol/l

0.25

173

1601

Primary open-angle glaucoma, strict

109

994

1.09

0.40

1.2

7.93

7.92

mmol/l

0.01

818

Central retinal artery occlusion

1.31

0.39

1.4

1.1

8.24

7.30

mmol/l

—

Assault by blunt object

1.42

0.39

1.2

1.4

8.46

7.44

mmol/l

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.39

0.0

1.1

—

7.82

—

Hypertrophy of breast in women and men

140

1296

1.08

0.39

1.3

1.4

6.98

7.08

mmol/l

0.18

135

1164

Non-selective monoamine reuptake inhibitors

221

1995

1.06

0.39

1.3

7.54

7.40

mmol/l

0.30

191

1727

Other and unspecified visual disturbances

579

1.12

0.39

1.4

1.3

6.96

7.19

mmol/l

0.32

515

ILD, hospital admissions 1, main diag only

494

1.13

0.38

1.2

7.10

7.66

mmol/l

0.94

416

Periodontal disease, other/unspecified

142

1.27

0.38

1.2

1.4

6.32

7.20

mmol/l

0.82

126

Dislocation, sprain and strain of joints and ligaments at neck level

125

1153

1.09

0.38

1.5

1.4

6.72

6.85

mmol/l

0.31

114

1051

Diarrhoea and gastroenteritis of presumed infectious origin

516

4783

0.96

0.38

1.3

1.4

7.19

7.01

mmol/l

0.81

458

4241

Other reaction to severe stress, and adjustment disorders

304

3192

0.95

0.38

1.4

6.83

6.81

mmol/l

0.04

278

2901

Schizophrenia

895

1.10

0.37

1.3

8.53

7.05

mmol/l

3.76

809

Erosion of teeth , including avohilmo

201

2137

0.94

0.37

1.3

1.4

6.72

6.86

mmol/l

0.37

181

1928

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

228

2152

1.06

0.37

1.3

7.20

7.16

mmol/l

0.08

204

1915

Benign neoplasm: Spinal meninges

1.36

0.37

1.2

10.86

7.47

mmol/l

—

Adenocarcinoma and ductal carcinoma of pancreas

114

0.70

0.37

1.5

1.2

9.34

7.45

mmol/l

—

Anxiety disorders, excluding more controls

686

4237

1.03

0.37

1.3

7.10

6.99

mmol/l

0.51

622

3744

Deep bite

535

1.12

0.37

1.4

6.76

7.01

mmol/l

0.38

483

Traumatic subdural haemorrhage

451

0.87

0.36

1.3

1.2

7.45

8.02

mmol/l

0.65

368

Persistent mood disorders

115

1246

0.92

0.36

1.3

1.4

7.29

7.03

mmol/l

0.48

105

1107

Nonorganic sleeping disorders, excluding more controls

160

1711

0.93

0.36

1.4

7.25

6.73

mmol/l

1.40

147

1530

Coronary artery bypass grafting

662

0.91

0.36

1.1

1.2

8.72

7.91

mmol/l

1.10

542

Voice disturbances

147

1577

0.93

0.36

1.3

7.05

7.34

mmol/l

0.73

135

1394

Secondary uncertain malignant neoplasm

545

0.88

0.36

1.2

8.21

7.70

mmol/l

0.48

456

Gastric ulcer

682

0.89

0.36

1.1

1.2

8.15

7.75

mmol/l

0.34

578

Malaise and fatigue

328

2704

0.95

0.36

1.3

7.04

7.15

mmol/l

0.27

280

2367

ILD, hospital admissions

554

1.12

0.36

1.2

7.26

7.68

mmol/l

0.61

466

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

469

1.13

0.36

1.4

7.21

7.18

mmol/l

0.02

418

Bell's palsy

608

0.89

0.36

1.3

7.26

7.31

mmol/l

0.05

544

Enterobiasis, including avohilmo

171

1.23

0.36

1.5

1.6

6.80

6.88

mmol/l

0.06

151

Malignant neoplasm of tonsil and base of tongue

0.65

0.36

1.0

1.2

8.10

7.32

mmol/l

—

Other melanin hyperpigmentation

0.65

0.36

1.0

1.3

7.86

7.14

mmol/l

—

Palindromic rheumatism

1.43

0.35

1.3

1.4

7.31

7.27

mmol/l

—

Hypotension due to drugs

1.43

0.35

1.3

1.2

9.95

7.31

mmol/l

—

Disorders of oesophagus in diseases classified elsewhere

0.62

0.35

1.0

1.2

6.18

8.22

mmol/l

—

Behavioural disorders

122

0.74

0.35

1.2

1.6

8.22

6.98

mmol/l

—

109

Conduct disorder

122

0.74

0.35

1.2

1.6

8.22

6.71

mmol/l

—

110

Other and unspecified polyneuropathies, also in other diseases

817

0.90

0.35

1.4

1.2

7.47

7.73

mmol/l

0.34

701

Status epilepticus

123

0.73

0.35

1.2

1.3

7.22

7.11

mmol/l

—

110

Otalgia

451

1.13

0.35

1.4

6.87

7.14

mmol/l

0.39

407

Cellulitis

120

1295

0.93

0.35

1.2

1.3

7.56

7.19

mmol/l

0.62

111

1153

Other local infections of skin and subcutaneous tissue

508

1.12

0.35

1.3

7.45

7.13

mmol/l

0.33

451

Coagulation defects, purpura and other haemorrhagic conditions

103

1118

0.92

0.35

1.4

1.3

7.19

7.15

mmol/l

0.06

994

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

145

0.76

0.34

1.8

1.3

6.61

7.35

mmol/l

0.80

124

In situ neoplasms

235

2478

0.95

0.34

1.3

1.4

7.63

7.23

mmol/l

1.03

206

2170

Congenital malformations of heart and great arteries

650

1.11

0.34

1.2

1.4

6.87

7.04

mmol/l

0.18

587

Paroxysmal tachycardia

144

1115

1.07

0.34

1.2

1.3

7.31

6.96

mmol/l

0.74

125

970

Myalgia

180

1693

1.06

0.34

1.4

6.81

7.06

mmol/l

0.68

156

1509

Reactive arthropathies, FINNGEN

358

1.15

0.34

1.2

1.3

6.38

7.20

mmol/l

1.33

321

Other diseases of lip and oral mucosa

261

2743

0.95

0.34

1.2

1.3

7.37

7.24

mmol/l

0.24

230

2427

Other heart diseases, wide

760

4462

1.03

0.34

1.2

1.4

7.14

7.01

mmol/l

0.66

695

3971

Melanocytic naevi

215

2271

0.95

0.34

1.4

6.77

7.03

mmol/l

0.80

189

2041

Benign neoplasm: Vagina

1.34

0.34

1.2

1.4

8.08

7.18

mmol/l

—

Acute sinusitis

424

3706

1.04

0.33

1.4

7.03

6.96

mmol/l

0.18

384

3311

Epilepsy

177

1660

1.06

0.33

1.2

1.3

7.20

7.25

mmol/l

0.09

160

1462

Ulcerative colitis, NAS

835

0.91

0.33

1.4

7.36

7.05

mmol/l

0.45

755

Erosion and ectropion of cervix uteri

127

1.26

0.33

1.6

1.4

6.53

7.19

mmol/l

0.54

114

Complications of surgical and medical care, not elsewhere classified

731

5019

0.97

0.33

1.3

7.29

7.06

mmol/l

1.45

661

4430

Other bacterial intestinal infections, including avohilmo

127

1364

0.93

0.33

1.3

6.99

7.29

mmol/l

0.69

112

1203

Other arthritis (FG)

203

1919

1.06

0.33

1.3

7.36

7.26

mmol/l

0.16

181

1685

Other and unspecified local infections of skin and subcutaneous tissue

491

1.12

0.33

1.3

7.45

7.11

mmol/l

0.33

436

Habit and impulse disorders

0.70

0.33

1.7

1.4

6.92

7.46

mmol/l

—

Fourth [trochlear] nerve palsy

0.70

0.33

1.0

1.4

6.17

7.16

mmol/l

—

Other bacterial intestinal infections

907

0.91

0.33

1.2

1.3

7.05

7.40

mmol/l

0.61

791

Malignant neoplasm of tonsil and base of tongue, including Hilmo

0.68

0.33

1.0

1.2

7.80

7.53

mmol/l

—

Prurigo nodularis

0.68

0.33

1.2

1.3

6.94

7.50

mmol/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

211

2227

0.95

0.33

1.4

7.32

6.95

mmol/l

1.01

191

2001

Disorders of parathyroid gland

865

0.91

0.33

1.2

7.79

7.60

mmol/l

0.19

746

Adenocarcinoma and papillary adenocarcinoma of stomach

0.67

0.32

1.3

1.2

7.58

7.97

mmol/l

—

Vitamin B12 deficiency anaemia

392

0.87

0.32

1.3

7.29

7.70

mmol/l

0.26

333

Valvular operations

561

0.89

0.32

1.1

1.2

7.77

7.68

mmol/l

0.06

467

Congenital malformations, deformations and chromosomal abnormalities

463

4546

0.96

0.32

1.4

7.05

6.92

mmol/l

0.54

419

4101

Injury, poisoning and certain other consequences of external causes

475

2294

1.04

0.32

1.4

7.03

6.95

mmol/l

0.26

429

2039

Disorders of refraction and accommodation

202

2125

0.95

0.32

1.3

1.4

6.71

6.96

mmol/l

0.78

178

1911

Burns and corrosions of multiple body regions

1.28

0.32

1.0

1.4

6.12

7.62

mmol/l

—

Disorders of vitreous body

285

2588

1.05

0.32

1.2

7.27

7.56

mmol/l

0.92

242

2244

Benign neoplasm of thyroid gland

146

1.24

0.32

1.1

1.4

6.42

7.52

mmol/l

1.53

123

Malignant neoplasm of pancreas, including Hilmo

306

0.85

0.32

1.3

1.2

8.51

7.76

mmol/l

0.60

254

L02BG Aromatase inhibitors

144

1517

0.94

0.32

1.3

7.56

7.42

mmol/l

0.25

131

1312

Ventral hernia

134

1252

1.07

0.32

1.3

1.2

7.42

7.50

mmol/l

0.11

119

1089

Hallux rigidus

607

1.10

0.32

1.2

7.43

7.70

mmol/l

0.34

524

Pyogenic granuloma

1.31

0.32

1.5

6.75

7.30

mmol/l

0.40

Congenital malformations and deformations of the musculoskeletal system

547

1.11

0.31

1.4

1.5

6.88

6.81

mmol/l

0.09

498

Childhood allergy (age < 16)

157

1216

1.07

0.31

1.8

1.6

6.17

6.32

mmol/l

0.49

148

1120

Endometriosis ASRM stages 3,4

154

1638

0.94

0.31

1.3

1.4

7.13

6.99

mmol/l

0.28

132

1464

Dislocation, sprain and strain of joints and ligaments of knee

515

4501

1.03

0.31

1.3

1.4

7.05

6.96

mmol/l

0.27

473

4028

Other disorders of veins

237

2449

0.95

0.31

1.3

7.07

7.35

mmol/l

0.83

197

2150

Interstitial lung disease endpoints

560

1.11

0.31

1.2

7.26

7.70

mmol/l

0.65

470

Interstitial lung disease

560

1.11

0.31

1.2

7.26

7.70

mmol/l

0.65

470

Benign neoplasm: Transverse colon

454

0.88

0.31

1.2

1.3

8.24

7.55

mmol/l

0.62

390

Hypokalaemia

522

1.11

0.31

1.2

8.30

7.53

mmol/l

1.13

458

Actinic keratosis

152

1298

1.07

0.31

1.2

7.63

7.92

mmol/l

0.50

122

1077

Sarcoidosis

618

1.10

0.31

1.2

7.40

7.46

mmol/l

0.06

548

Human immunodeficiency virus [HIV] disease, including avohilmo

0.73

0.31

1.3

7.56

7.18

mmol/l

—

Disorder of the sleep-wake schedule

0.71

0.31

1.4

7.53

7.01

mmol/l

—

Malignant melanoma, including Hilmo

799

0.91

0.31

1.2

7.62

7.55

mmol/l

0.06

671

Monoamine oxidase A inhibitors

580

1.10

0.31

1.3

1.2

7.57

7.41

mmol/l

0.15

510

Primary open-angle glaucoma

129

1160

1.07

0.30

1.2

7.76

7.88

mmol/l

0.19

112

954

Stenosis and insufficiency of lacrimal passages

409

1.13

0.30

1.4

1.3

6.51

7.53

mmol/l

3.06

358

Use of biperiden

221

1.18

0.30

1.3

9.05

7.37

mmol/l

1.77

197

Benign neoplasm: Skin of trunk

184

1.20

0.30

1.3

7.55

7.34

mmol/l

0.09

162

Disorders of vitreous body and globe

293

2652

1.04

0.30

1.2

7.24

7.55

mmol/l

1.05

248

2297

D07AA Corticosteroids, weak (group I)

1066

0.93

0.30

1.6

1.4

6.72

6.87

mmol/l

0.25

974

Iron deficiency anaemia secondary to blood loss (chronic)

715

1.09

0.30

1.2

1.3

7.51

7.59

mmol/l

0.07

611

Other and unspecified drugs and medicaments

419

1.12

0.30

1.4

1.3

7.23

7.25

mmol/l

0.01

373

Ectopic pregnancy

131

1227

1.07

0.30

1.6

1.4

6.89

7.00

mmol/l

0.20

118

1114

ILD, hospital admission 2, with pulmonary infections

357

0.87

0.30

1.2

7.44

7.42

mmol/l

0.01

291

Localized skin eruption due to drugs and medicaments

1.28

0.30

1.0

1.3

7.20

7.19

mmol/l

—

Pedestrian injured in other and unspecified transport accidents

1.28

0.30

1.3

6.67

7.42

mmol/l

—

Normotensive glaucoma

293

0.85

0.30

1.2

8.28

7.88

mmol/l

0.24

242

Other interstitial pulmonary diseases

562

1.10

0.30

1.2

7.26

7.71

mmol/l

0.66

471

Conduction disorders

135

1153

0.94

0.30

1.2

7.83

7.54

mmol/l

0.44

124

972

Implicit viral Sepsis, including avohilmo

162

1712

0.94

0.30

1.3

7.28

7.32

mmol/l

0.06

141

1476

Dermatitis due to substances taken internally

282

0.85

0.30

1.2

1.4

6.61

7.22

mmol/l

0.84

251

Contact with other sharp object(s)

410

1.12

0.29

1.4

7.25

6.85

mmol/l

0.39

371

Psoriasis vulgaris

113

1054

1.07

0.29

1.4

1.3

7.75

7.20

mmol/l

1.12

102

943

Cutaneous abscess, furuncle and carbuncle

185

1754

1.06

0.29

1.5

1.3

7.23

7.06

mmol/l

0.33

170

1576

Hypertrophy of breast

128

1200

1.07

0.29

1.3

1.4

7.01

7.04

mmol/l

0.05

123

1076

Melanocytic naevi of other and unspecified parts of face

335

1.14

0.29

1.6

1.4

6.76

7.17

mmol/l

0.46

297

Dyspnoea

633

4696

0.97

0.29

1.3

7.35

7.11

mmol/l

1.34

552

4151

Injuries to the knee and lower leg

970

5120

1.02

0.29

1.3

7.12

7.03

mmol/l

0.49

871

4537

Chronic suppurative otitis media, including avohilmo

354

1.13

0.29

1.2

1.4

6.66

7.09

mmol/l

0.70

315

Bacterial intestinal infections, IBD co-morbidities

899

0.92

0.28

1.2

1.3

7.05

7.41

mmol/l

0.65

790

Other congenital malformations

535

1.10

0.28

1.8

1.5

6.88

6.86

mmol/l

0.03

485

Superficial injury of hip and thigh

753

0.92

0.28

1.3

7.33

7.37

mmol/l

0.04

652

Injuries to the ankle and foot

609

5053

1.03

0.28

1.5

1.4

6.77

6.99

mmol/l

1.32

561

4506

Acute pancreatitis (for exclusion)

971

0.93

0.28

1.3

1.2

8.01

7.52

mmol/l

0.74

850

Atopic dermatitis, strict definition with reimbursement

284

2617

1.04

0.28

1.5

1.4

6.70

6.71

mmol/l

0.03

263

2379

Biological medication for rheuma

117

1249

0.94

0.28

1.5

1.4

7.22

6.96

mmol/l

0.39

111

1133

Chondropathies

102

950

1.07

0.28

1.3

1.4

7.12

7.07

mmol/l

0.08

859

malignant neoplasm of female genital organs

705

0.91

0.28

1.2

1.3

8.03

7.53

mmol/l

0.55

601

Postmenopausal atrophic vaginitis

137

701

1.07

0.27

1.2

7.29

7.45

mmol/l

0.28

119

610

Unspecified acute lower respiratory infection

854

1.08

0.27

1.3

7.73

7.19

mmol/l

0.97

764

Vocal cord dysfunction

683

1.08

0.27

1.3

7.12

6.34

mmol/l

1.97

606

Abnormal involuntary movements

700

1.09

0.27

1.2

1.3

7.04

7.24

mmol/l

0.23

625

Other problems related to primary support group, including family circumstances

831

1.08

0.27

1.5

6.87

6.85

mmol/l

0.02

761

Wet age-related macular degeneration

499

1.10

0.27

1.2

8.60

8.08

mmol/l

0.42

388

Osteopathies and chondropathies

339

3212

0.96

0.27

1.3

7.11

7.26

mmol/l

0.43

304

2814

Lesion of ulnar nerve

768

1.08

0.27

1.3

1.2

7.45

7.35

mmol/l

0.09

681

Use of ropinirole

121

0.74

0.27

1.3

1.2

7.86

7.47

mmol/l

—

102

Later onset COPD, excluding more controls

549

0.92

0.27

1.2

8.11

7.91

mmol/l

0.24

428

Carcinoma in situ of skin

290

1.14

0.27

1.2

7.69

7.86

mmol/l

0.10

242

Peripheral arterial reconstruction

563

0.91

0.27

1.2

8.08

7.96

mmol/l

0.09

466

Shoulder region

1.22

0.27

1.4

1.3

6.00

7.26

mmol/l

—

FESS (DNB20)

719

0.92

0.26

1.3

7.75

7.20

mmol/l

0.38

643

Other diseases of gallbladder

159

1.20

0.26

1.0

1.3

7.19

7.41

mmol/l

0.12

135

Separation of retinal layers (serosa)

187

1.18

0.26

1.4

1.2

8.68

7.38

mmol/l

0.44

165

Malignant neoplasm of stomach, including Hilmo

193

0.83

0.26

1.2

8.19

7.85

mmol/l

0.11

158

Previous suicide attempt

1.20

0.26

1.3

1.5

6.66

7.67

mmol/l

—

Benign neoplasm: Caecum

426

0.89

0.26

1.1

1.2

7.43

7.57

mmol/l

0.11

363

Abnormal findings in nipple discharge synovial fluid wound secretions

0.70

0.26

1.0

1.5

9.34

7.37

mmol/l

—

Foreign body on external eye

818

1.08

0.26

1.2

1.3

7.67

7.16

mmol/l

0.90

727

Wegener granulomatosis

0.69

0.26

1.0

1.3

7.64

7.28

mmol/l

—

Dissocial personality disorder

0.68

0.26

1.2

1.3

8.00

7.24

mmol/l

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

0.68

0.26

1.2

1.3

8.54

7.26

mmol/l

—

Malignant neoplasm of oropharynx, including Hilmo

0.66

0.26

1.0

1.2

8.10

7.40

mmol/l

—

Benign neoplasm: Skin of other and unspecified parts of face

453

1.10

0.25

1.1

1.3

7.24

7.37

mmol/l

0.11

396

Exclusions for E4_PCOS_BROAD

111

1041

1.07

0.25

1.2

1.4

7.59

7.08

mmol/l

0.85

103

940

Otitis media, unspecified

736

1.08

0.25

1.5

6.70

mmol/l

0.00

667

Other diseases of spinal cord

127

0.79

0.25

1.3

1.4

10.37

7.61

mmol/l

—

109

conjunctival haemorrhage

301

1.13

0.25

1.2

1.3

7.62

7.48

mmol/l

0.05

260

Other diseases of urinary system

808

4431

1.02

0.25

1.4

7.05

7.02

mmol/l

0.15

733

3924

Hyperkinetic disorders (excl. ADHD)

1.20

0.25

1.4

1.6

7.85

7.11

mmol/l

—

Hypotension

612

0.91

0.25

1.2

8.08

7.83

mmol/l

0.20

502

Benign neoplasm: Long bones of lower limb

159

0.82

0.25

1.5

1.3

7.09

7.32

mmol/l

0.11

140

Ovarian hyperstimulation (induction)

170

1.18

0.24

1.8

1.6

6.95

6.57

mmol/l

0.28

154

Adhesive middle ear disease

1.19

0.24

1.8

1.5

7.52

7.13

mmol/l

—

Oxicams

143

768

1.06

0.24

1.2

1.4

7.25

7.08

mmol/l

0.24

125

652

Zoster [herpes zoster]

879

1.07

0.24

1.3

7.45

mmol/l

0.00

765

Anti-inflammatory and antirheumatic products, non-steroids

201

965

1.05

0.24

1.4

7.20

6.89

mmol/l

0.69

178

829

Cardiodefibrillation

153

1449

1.05

0.24

1.2

7.89

7.79

mmol/l

0.13

130

1211

Superficial injury of forearm

657

1.08

0.24

1.2

1.4

7.18

6.91

mmol/l

0.44

606

Fracture of skull and facial bones

123

1302

0.94

0.24

1.2

1.3

7.56

7.28

mmol/l

0.38

105

1160

Purpura and other haemorrhagic conditions

673

0.92

0.24

1.5

1.3

7.27

7.28

mmol/l

0.01

594

Other and unspecified acute skin changes due to ultraviolet radiation

1.28

0.24

1.2

7.63

7.44

mmol/l

—

Simple and mucopurulent chronic bronchitis

126

0.79

0.24

1.5

1.2

7.63

7.44

mmol/l

—

103

Mandibular retrognathia

387

1.11

0.24

1.3

1.4

6.33

6.86

mmol/l

0.77

353

Cleft lip, lip and palate or palate

0.71

0.24

1.3

1.5

6.12

7.43

mmol/l

—

Artificial opening status

212

0.85

0.24

1.3

7.74

7.49

mmol/l

0.14

179

Bipolar affective disorders

158

1504

1.05

0.24

1.4

7.50

6.80

mmol/l

2.55

144

1354

All anxiety disorders

561

4241

1.03

0.23

1.4

6.94

6.89

mmol/l

0.18

518

3812

Other and unspecified dermatitis

377

3655

1.03

0.23

1.4

1.3

6.99

7.15

mmol/l

0.53

325

3239

Other disorders of kidney and ureter

568

0.91

0.23

1.2

7.26

7.48

mmol/l

0.19

494

Benign neoplasm: Nasopharynx

1.32

0.23

1.2

1.3

6.30

7.78

mmol/l

—

Glaucoma secondary to eye inflammation

1.32

0.23

1.2

1.3

6.54

7.24

mmol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

251

2139

0.96

0.23

1.3

1.2

7.79

7.65

mmol/l

0.31

215

1818

Allergic colitis

106

1.23

0.23

1.8

1.6

6.63

6.44

mmol/l

0.17

Other mosquito-borne viral fevers, including avohilmo

1.29

0.23

1.6

1.4

6.38

8.00

mmol/l

—

Delayed puberty

1.29

0.23

1.4

1.7

5.36

7.37

mmol/l

—

Burns and corrosions of multiple and unspecified body regions

1.24

0.23

1.3

1.4

8.06

7.50

mmol/l

0.12

Asthma and allergy

110

1024

1.06

0.23

1.5

1.4

6.39

6.65

mmol/l

0.52

103

908

Diffuse large B-cell lymphoma, helper endpoint

168

0.83

0.22

1.1

1.2

6.88

7.90

mmol/l

1.23

141

Diffuse large B-cell lymphoma

168

0.83

0.22

1.1

1.2

6.88

7.90

mmol/l

1.23

141

Diffuse large B-cell lymphoma, including Hilmo

168

0.83

0.22

1.1

1.2

6.88

7.90

mmol/l

1.23

141

Isolated patent ductus arteriosus

1.27

0.22

1.2

1.8

5.66

7.42

mmol/l

—

Viral and other specified intestinal infections, including avohilmo

230

2300

0.96

0.22

1.5

6.74

6.67

mmol/l

0.14

206

2085

Palmar fascial fibromatosis [Dupuytren]

563

1.08

0.22

1.1

1.2

7.98

7.83

mmol/l

0.11

473

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

773

4984

0.98

0.22

1.3

1.4

7.27

7.00

mmol/l

1.78

691

4424

Hereditary motor and sensory neuropathy

1.25

0.22

1.0

1.2

6.42

7.92

mmol/l

—

Marginal zone B-cell lymphoma

1.25

0.22

1.4

1.2

6.96

7.49

mmol/l

—

Benign neoplasm: Duodenum

0.75

0.22

1.7

1.2

8.06

7.41

mmol/l

—

Fall on and from stairs and steps

155

1625

0.95

0.22

1.3

7.05

7.25

mmol/l

0.42

139

1435

Spontaneous rupture of synovium and tendon

358

0.89

0.22

1.4

1.2

7.35

7.62

mmol/l

0.22

308

Any mental disorder

851

4347

0.98

0.22

1.3

7.35

7.02

mmol/l

2.50

765

3830

Human immunodeficiency virus [HIV] disease

0.73

0.22

1.3

7.56

7.18

mmol/l

—

Tumor necrosis factor alpha inhibitors

107

1133

0.94

0.22

1.5

1.4

7.22

6.97

mmol/l

0.33

101

1027

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

714

1.07

0.22

1.4

1.5

6.88

mmol/l

0.00

653

Family history of malignant neoplasm

814

0.93

0.22

1.4

6.65

6.98

mmol/l

0.55

733

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS